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VABSTRACT
Studies undertaken to identify the abnormality 
predisposing to malignant hyperpyrexia (MH) and to 
assess the reliability of diagnostic methods have 
led to a number of significant findings which have 
resolved some of the previously unanswered 
questions about MH.
The in vitro contracture response, ascribed to 
succinylcholine, is due to the preservatives in the 
pharmaceutical preparations. Halothane- and 
caffeine- induced contractures provide the most 
reliable indication of MH susceptibility, while 
KC1- and Anectine-induced contractures can be used 
to confirm the diagnosis.
The depolarization of the sarcolemma by 
halothane and caffeine was temperature dependant. 
While a 5-10mV depolarization was observed at 37°C, 
there was no effect on the resting membrane 
potential at 25°C. It is proposed that the 
depolarization could be due to a release of calcium 
from the sarcoplasmic reticulum into the myoplasm.
31P NMR studies of whole muscle were used to 
demonstrate that, on exposure to 3% halothane or 
2mM caffeine, MHS muscle was able to maintain the 
ATP concentration at resting levels. This occurred 
at the expense of phosphocreatine, with a 
consequent accumulation of inorganic phosphate.
The site of the muscle cell membrane 
abnormality in MH, and the metabolic changes which 
occur in MH, are discussed in the light of these 
new observations.
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1CHAPTER 1 - INTRODUCTION
1.1 BACKGROUND
Malignant hyperpyrexia(MH) is a syndrome induced in 
susceptible individuals by certain chemical stimuli, 
including halothane, one of the most widely used 
anaesthetic agents. Since its first description in 1960 
by Denborough and Lovell, MH has received considerable 
attention as groups of clinicians and scientists around 
the globe have attempted to determine the aetiology and 
pathopharmacology of this serious complication of 
general anaesthesia.
Originally identified as a hypersensitivity to 
halothane, MH has been shown to be triggered by most 
inhalation anaesthetic agents including halothane, 
methoxyflurane, diethyl ether, ethyl chloride, 
trichloroethylene and cyclopropane, and by the muscle 
relaxants succinylcholine and gallamine. Although first 
recognised as a rapid increase in body temperature, it 
became evident that MH is manifested in a number of 
ways, all with serious implications for the well-being 
of the anaesthetised patient. Some of the clinical 
features now associated with MH are tachycardia, muscle 
rigidity, acidosis and disturbance of serum electrolyte 
balance (Denborough, 1975; Ellis,1981). In the 10 years 
following the description of the disease the mortality 
rate was estimated to be 60-70 per cent, despite 
efforts to treat the symptoms of fulminant episodes of 
MH (Britt and Kalow, 1970a).
2An editorial in the British Medical Journal in 1968 
first suggested that MH was related to an underlying 
disease of skeletal muscle (King, Denborough and Zapf, 
1971) . The most common myopathy, upon which most of 
this thesis is based, is dominantly inherited and 
usually subclinical (Denborough, Ebeling, King and 
Zapf, 1970a; Isaacs and Barlow, 1970; King, Denborough 
and Zapf, 1972). Other myopathies include a second 
dominantly inherited disease, showing "central cores" 
in the skeletal muscle fibres (Denborough, Dennet and 
Anderson, 1973a), and a recessive trait, occurring in 
young boys, which is associated with a number of 
physical deformities (King and Denborough, 1973a).
Recent reports have associated MH with two 
incidents of heat stroke. The symptoms were similar to 
those described for MH and dantrolene sodium, a drug 
used in MH therapy, was effective in reversing the high 
temperature and acidosis in both cases (Lydiatt and 
Hill, 1981; Denborough, 1982). An in-vitro muscle 
test, designed to test susceptibility to MH, showed the 
muscle from one of these patients to have an increased 
sensitivity to caffeine and halothane (Denborough, 
1982) . It has further been suggested that MH is one of 
the underlying causes of the sudden infant death 
syndrome, or "cot-death" (Denborough, 1981; Denborough, 
Galloway and Hopkinson, 1982).
3Despite ever-increasing work in this area, the 
primary defect is still unknown.
1.2 IDENTIFICATION OF SUSCEPTIBILITY
In order to reduce the number of MH fatalities it 
is necessary to be able to determine the susceptibility 
of an individual before the administration of a known 
triggering agent. The most reliable method of making 
such a diagnosis is the in vitro exposure of skeletal 
muscle biopsy specimens to a variety of chemical agents 
(Moulds and Denborough, 1974b; Moulds and Denborough, 
1974c).
This diagnosis utilises the determination of muscle 
contracture responses to one or more of the drugs, 
halothane, caffeine, potassium and succinylcholine. 
Around the world, a diverse range of tests is used and 
although each group has its own standardised tests, the 
variation in results is significant. While some 
laboratories determine the magnitude of the response at 
a fixed concentration, others determine the threshold 
concentrations at which contracture occurs, and others 
use a combination of both. Variations also include 
different temperatures, different drug combinations, 
alternative methods of preparing the sample and 
differences in the cut-off points at which the muscle 
is classified as susceptible. Of more concern are the 
differing results obtained using what appear to be
similar methods.
4Currently, the most urgent need is to discover 
better methods of diagnosis. The protocols used need to 
be standardised and more fully defined, or better 
still, new, accurate, non-invasive techniques 
developed. Only then would it become feasible to test 
the general population.
1.3 MH IN ANIMALS
One of the most useful discoveries aiding research 
into MH was the identification of an experimental 
model, the pig (Hall, Woolf, Bradley and Jolly, 1966); 
Harrison, Biebuyck, Terblanche, Dent, Hickman and 
Saunders, 1968; Gronert and Theye, 1976; Harrison,
1979). There has been extensive research comparing 
responses of MH susceptible (MHS) swine with those of 
MHS humans. The initial observations involved in vivo 
comparisons, however, for research purposes it was 
necessary to compare the in vitro responses of MHS 
muscle from humans with those from pigs. Recent 
investigations have shown that MHS swine muscle has 
identical pharmacological properties to MHS human 
muscle(Okumura, Crocker and Denborough, 1979). Although 
the syndrome in pigs has not been proven identical to 
human MH, the availability of an animal model has 
enabled a considerable amount of basic research to be 
carried out on MH, which would not otherwise have been 
possible.
5One of the most significant areas of research has 
been the initial testing of alternative forms of 
anaesthesia, in search of a safe anaesthetic, as well 
as the testing of therapeutic drugs to be used in the 
prevention or treatment of fulminant MH. Research into 
muscle biochemistry and physiology has been made 
possible by the use of pigs, from which large 
quantities of tissue can be removed, thus enabling the
isolation of membrane fractions(Gronert, Heffron and 
Taylor, 1979; Jardon, Barak, Noffsinger, Chopin and 
Wingard, 1980; Sullivan, Galloway and Denborough, 
1982), mitochondria (Cheah and Cheah, 1979; Gronert and 
Heffron, 1979) and muscle enzymes(Marjanen and 
Denborough, 1982a). Other studies, only possible in an 
experimental animal, have involved triggering the
syndrome and observing the biochemical changes within 
the blood and the muscle in relation to the development
and expression of the various signs (Berman, Harrison,
Bull and Kenck, 1970).
MH in pigs has been associated with a number of
other stress related syndromes described in certain 
breeds of swine. These are the porcine stress 
syndrome(PSS) and the pale soft exudative pork syndrome 
(PSEP). The common denominator appears to be 
susceptibility to loss of control of skeletal muscle 
metabolism(Nelson, 1973; Denborough, 1980).
61.4 PROJECT AIMS
The effect of drugs on MHS muscle has been studied 
using a variety of techniques, to firstly investigate 
methods of diagnosis of MH and secondly, to try to 
increase understanding of the primary defect in MH. A 
multidisciplinary approach has been used to discover 
possible links between the pharmacological, 
physiological and biochemical aspects of muscle 
function with relation to MH.
Pharmacological studies, both in vitro and in vivo 
have been directed mainly towards the diagnosis of MH.
An attempt has been made to resolve some of the
differences expressed by workers in this field,
regarding the suitability of succinylcholine as an
agent for the in vitro testing of MH susceptibility. 
This work has also provided some insight into the 
in vivo action of succinylcholine in MHS swine.
The various diagnostic methods have been analysed 
in detail, with the aim of defining the significance 
and reliability of each test. In this way a protocol 
for the investigation of MH susceptibility in humans 
has been devised.
Another conflict in the literature has been the 
effect of halothane on the resting membrane potential 
of MHS porcine muscle. Studies in this thesis have 
aimed to resolve this conflict . Further experiments 
carried out to study the effect of halothane and 
caffeine on the resting membrane potential of MHS
7muscle have been used to define the site of the 
primary abnormality in MHS muscle.
Nuclear magnetic resonance was used to study
metabolism in erythrocytes, with the aim of finding
some difference between blood from MHS and control 
patients which could then be used for diagnostic
purposes. NMR was also used to investigate some of the 
biochemical effects of halothane and caffeine on MHS 
and control muscle. The phosphate metabolite profiles, 
before and after exposure to halothane and caffeine, 
have provided a dynamic method for studying the 
hypermetabolic state induced in MHS muscle by these
drugs. Due to a series of technical difficulties these 
studies were curtailed, but further experiments are 
suggested that should provide more information on this 
aspect of MH.
8CHAPTER 2 - SITE OF THE MUSCLE CELL ABNORMALITY
2.1 SKELETAL MUSCLE
2.1.1 Muscle structure
Two main functions of muscle are controlling 
movement by the shortening of muscles connected to the 
bones, and the ability to support a load. Both 
functions are due to muscle contraction which occurs as 
the result of movement of macromolecules within the 
muscle cell. In order to understand muscle disease and 
the effect of various stimuli, it is necessary to 
consider the structure of muscle and the mechanism by 
which chemical energy is converted into mechanical 
energy.
When viewed under a light microscope, a striated 
muscle fibre consists of a number of myofibrils, each 
of which is made up of alternate light and dark bands. 
The myofibrils are further divided into myofilaments, 
which are the contractile proteins. The relationship 
between the myofilaments and the light and dark bands 
was first explained by using the electron microscope to 
show an overlapping double array of thick and thin 
filaments (H.E.Huxley and Hansen, 1954). The thick 
filaments, which are about 12nm in diameter, determine 
the extent of the A-bands of the fibrils. The thin 
filaments are only 7nm in diameter, and although they 
occur in the I-band, they also extend into the A-band.
9The sliding filament theory, developed
independently by H.E Huxley and Hansen (1954) and by 
A.F. Huxley and Niedergerke (1954), is now accepted as 
the structural basis of contraction. Simply, this 
theory states that when muscle contracts, the 
individual filaments do not change in length but merely 
slide over one another, so that the I-band (the area 
not occupied by thick filaments) tends to shorten. 
Cross-bridges extending from the thick filaments to the 
adjacent thin filaments are responsible for developing 
the tension (Treager and Marston, 1979).
The myofilaments have since been shown to consist
of proteins. The structural proteins in muscle are 
* shown in Table 2.1. All the myosin is located in the
thick filaments and the A-band disappears when the 
myosin is dissolved. The myofilaments are spaced on a 
hexagonal lattice with a distance of 45nm between each 
filament. Electron microscopic observation by H.E. 
Huxley (T963) showed that projections from the myosin 
filaments spanned all or most of the 13nm gap to the 
actin filaments linking the two types together. These 
projections, referred to as cross-bridges, are now 
known to be head groups on the myosin molecules
(Trinick and Elliot, 1979). The thin filaments consist
of a double helix of actin molecules with a strand of 
tropomyosin lying alongside each groove. An additional 
protein, troponin, is also located on the thin
filaments and this is a tri-subunit complex containing 
(i)troponin-C, the calcium binding segment,
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(ii)troponin-T, the segment responsible for
troponin-tropomyosin interaction and (iii)troponin-I; 
the inhibitory subunit, which in resting muscle, 
physically blocks the interaction of actin with myosin 
(Murray and Weber,1974; Perry,1979). A simplistic 
representation of the interaction between the thick and 
thin filaments and the mechanism by which they cause 
contraction is illustrated in Figure 2.1.
TABLE 2.1 Relative proportions of myofibrillar 
proteins in Skeletal Muscle
Protein % of total structural protein
Myosin 55
Actin 20
Tropomyosin 7
Troponin 2
C-protein 2
m-proteins h2
a-Actin 10
b-Actin 2
2.1.2 The contractile process
The actin and myosin interaction requires the
2+  . -6 concentration of Ca ions to reach greater than 10 M,
about ten times that in resting muscle. The mechanism
by which the Ca is increased makes use of a complex
membrane system, as shown in Figure 2.2A. The outer
muscle membrane, or sarcolemma, provides communication
with the outside by interacting with the nervous system
Figure 2.1 Interaction between thick and thin filaments 
of skeletal muscle
A. Thick and thin filaments interdigitate in an orderly 
array to form a muscle fibre. Two sets of thin 
filaments extend towards each other from adjacent 
z-lines. The head groups of the myosin molecules act as 
bridges between the thick and thin filaments by 
interacting with the actin molecules.
B. Muscle contracts when a nerve signal initiates a 
sequence of events that cause the myosin heads to 
attach to the actins, swivel and then break contact.
C. In this way the thin filaments are propelled towards 
each other and the muscle shortens. (From Murray and
Weber, 1974)
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Figure 2.2 Relationships between myofibrils and 
membrane systems in skeletal muscle.
A. A schematic representation of the organisation of 
myofibrils, sarcoplasmic reticulum and t-tubules withih 
a muscle fibre. (From Bowman and Rand, 1980)
B. Electron micrograph of human vastus lateralis muscle 
showing a longitudinal section view of two sarcomeres 
of a myofibril (Courtesy of K.C. Hopkinson).
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at the neuromuscular junction. Radiating into the 
muscle from the sarcolemma are membrane projections 
called t-tubules. These structures occur in the region 
of the z-line, where they come into close proximity 
with the sarcoplasmic reticulum (SR).
The SR consists of two sections, the terminal
cisternae or lateral sacs, and the longitudinal
cisternae.In mammalian skeletal muscle the terminal
cisternae are located on both sides of the t-tubule,
2 +and it is from these vesicles that Ca is released
during contraction. The longitudinal cisternae extend
2 +between the z-lines and sequester Ca during
relaxation.
2.1.3 The neuromuscular junction
The chain of events which leads to muscle
contraction is triggered by a depolarization of the 
sarcolemma from its resting value of about -90mV to a 
value of -50mV. This is achieved by the release of 
acetylcholine from the nerve endings in response to 
depolarisation of the nerve. The acetylcholine diffuses 
across the junction gap and combines fleetingly with 
specific macromolecules called receptors, which are 
located on the exterior face of the postjunctional 
motor endplate membrane. The result of this interaction 
is a localised increase in the membrane cation
permeability (Ginsborg and Jenkinson, 1976). This 
causes a net movement of cations through the endplate 
membrane in accordance with their concentration
14
gradients and equilibrium potentials.
2,1,4 Intra-cell communication
The depolarization of the sarcolemma is translated
to the sarcoplasmic reticulum via a process known as
excitation-contraction (E-C) coupling. A model for the
E-C coupling mechanism is presented in Figure 2.3. In
2 +the resting cell, the free Ca concentration in the
myoplasm (Ca ) is below the threshold level for
2 +mechanical activation. The free Ca concentration in
the triadic junction (Ca^j) is in equilibrium with -Ca-
and is presumably the same. Most of the cell calcium is
sequestered in the terminal cisternae of the
sarcoplasmic reticulum • The trigger calcium
(Ca^) is shown bound to the intracellular surface of
2 +the t-tubular membrane. Also, Ca ^ ats^ loosely
bound to the luminal surface of the t-tubular membrane
2+is in equilibrium with extracellular Ca in the lumen 
of the t-tubule.
When the t-tubular membrane is depolarised, either 
by a nerve impulse or by a chemical activator, some of 
the trigger calcium is released into the triadic
junction. It diffuses across this junction during the 
latent period to reach and act on the terminal 
cisternae membrane, thereby causing the release of CagR 
into the myoplasm, and raising the [Cam ]^ above the 
threshold concentration required to produce a 
mechanical response.
15
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Figure 2.3 E-C Coupling in skeletal muscle.
A working model for the trigger calcium mechanism for 
E-C coupling showing calcium fluxes for resting, 
contracting and relaxing muscle. The t-tubule is on the 
right and the terminal cisternae is on the left. 
Abbreviations: t, t-tubular lumen; ts, luminal surface 
of t-tubular membrane; mb, t-tubular membrane; tj, 
triadic junction; my, myoplasm; E, efflux; I, influx. 
(From Frank, 1980)
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Recovery (or relaxation) is brought about by active 
processes pumping the Cam^ back into the sarcoplasmic
reticulum or out of the fibre. During recovery, the
Camb must also be restored to resting levels. This is
particularly important in the normal physiological
functioning of skeletal muscle fibres in which isolated 
action potentials are rare and activity tends to come
in small bursts.
2.1,5 Energetics and metabolism in skeletal muscle
ATP is required at several steps in the
contraction-relaxation cycle. ATP provides the energy
for the activation of myosin for cross-bridge formation
and for the uptake of calcium ions by the sarcoplasmic
reticulum during relaxation. It also enables inhibition
2 +of cross-bridge formation by interaction with Ca -free 
troponin-tropomyosin complex. ATP is the only 
high-energy compound directly used by the contractile 
apparatus. However, it is rapidly regenerated by two 
processes: transphosphorylation from phosphocreatine to
ADP under the influence of creatinephosphokinase (CPK), 
and, to some extent, by rearrangement of ADP with the 
accumulation of AMP under the influence of adenylate 
kinase.
Two other processes lead to the resynthesis of ATP 
in the muscle cell, namely anaerobic glycolysis which 
produces lactic acid, and oxidative phosphorylation 
within the mitochondria. Although all muscle fibres use 
both these processes, the relative proportion of ATP
17
produced by each pathway varies between different 
muscle fibres.
Originally the two types of muscle fibre were 
referred to as red and white fibres, based on the 
different amounts of myoglobin present. A high 
myoglobin content gave a red colour and also indicated 
a higher oxidative capacity, since myoglobin is an 
oxygen-binding haemprotein. White fibres were believed 
to be mainly glycolytic fibres. Advances in techniques 
used for examining muscle fibres have recently 
indicated that red fibres are not a homogeneous group, 
and that they should be divided into at least two 
subgroups. The properties of the various fibre-types 
are presented in Table 2.2.
Type 1 fibres (slow-twitch oxidative) have low 
contraction speeds, low glycolytic capacities and are 
rich in mitochondria and myoglobin. They have a red 
appearance and are adapted for steady, continuous 
output without fatigue.
Type 2A fibres (fast-twitch oxidative-glycolytic) 
combine high contraction speeds with an abundance of 
mitochondria and a high glycolytic capacity. They also 
have a red colour due to their high myoglobin content, 
and are resistant to fatigue.
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TABLE 2.2 Some properties of Types 1, 2A and 23 fibres in 
mammalian muscles (From Bowman and Rand, 1979)
Property Type 1 Type 2A Type 2B
Old classification Intermediate Red White
Myoglobin content high high low
Glycogen content low high intermediate
Lipid droplets high high low
Oxidative enzyme high high low
activity
Mitochondrial ATPase intermediate high low
activity
Glycolytic activity low intermediate high
Myosin ATPase activity low high high
Mitochondrial content intermediate high low
Z-membrane intermediate broad narrow
Neuromuscular junction intermediate small and large and
simple complex
Sarcoplasmic reticulum sparser than well well
other two developed developed
2 +Ca -accumulating slow rapid rapid
ability of SR
Twitch speed slow fast fast
Susceptibility to resistant to fatigues fatigues
fatigue fatigue slowly easily
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Type 2B fibres (fast twitch glycolytic) have high 
contraction speeds and a high glycolytic capacity, but 
are low in mitochondria and myoglobin, leading to a 
pale appearance and a low resistance to fatigue. They 
have a relatively poor capillary blood supply,and rely 
mainly on stored glycogen for energy production, 
although their maximal work output may be very high for 
short periods.
2,1,6 Summary
The series of events in the contraction-relaxation 
cycle are illustrated in Figure 2.4, indicating those 
processes which use energy in the form of ATP. The 
manner in which ATP is regenerated has been described.
Having reviewed the physiology of muscle function, 
possible defects which could lead to malignant 
hyperpyrexia may be suggested.
2,2 SKELETAL MUSCLE AND MALIGNANT HYPERPYREXIA.
Growing evidence attributing the primary MH defect 
to skeletal muscle abnormality has indicated the need 
for further studies of the nature of muscle structure. 
These investigations have suggested that the lesion is 
present in almost every stage of the muscle contraction 
process (See Figure 2.4).
20
Depolarization of plasma membraneI
Electrical disturbance conducted along T-tubulesI2 +Trigger Ca released from triadic junctionsI2 +Activator Ca released from lateral sacs and vesicles of SR
2 + ITroponin binds Ca and removes maintained relaxation____ i
Myosin ATPase activated and ATP hydrolysedIFormation of cross-bridges between actin and myosin 
and interdigitation of filamentsI
CONTRACTION
Actin and Myosin filaments separatelRELAXATION
Figure 2.4 Events in the contraction-relaxation cycle. Steps 
involving ATP are enclosed within boxes. SR = sarcoplasmic 
reticulum. (From Bowman and Rand, 1979)
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2.2.1, Depolarisation of the sarcolemma
Halothane has been shown to produce a 5-10mV 
depolarization of the plasma membrane in MHS muscle, 
but not in control muscle (Gallant, Godt and Gronert, 
1979; Galloway, Bornstein and Denborough, 1980). 
Although in normal muscle a depolarisation of this
magnitude would not be sufficient to cause a
f\
contracture, the results could be explained by a lower 
mechanical threshold in MHS muscle (Bryant and 
Anderson, 1977).
2.2.2, E-C Coupling mechanism
The model shown in Figure 2.5 has been used to 
explain observations relating to the effect of 
dantrolene sodium on halothane and caffeine potentiated 
twitch (Nelson and Denborough, 1977). As dantrolene 
sodium was able to block the halothane induced twitch 
potentiation, it was suggested that the two drugs acted 
at the same site within the E-C coupling mechanism 
(Ellis and Bryant, 1972; Ellis and Carpenter 1972; 
Putney and Bianchi, 1974). The absence of a dantrolene 
sodium effect on caffeine potentiation of twitch showed 
that these two agents acted at different sites.
Dantrolene sodium has also been shown to inhibit 
and to reverse contractures induced in MHS muscle by 
halothane (Anderson and Jones,1976), caffeine, 
potassium chloride and succinylcholine (Austin and 
Denborough, 1977). This suggests that all four drugs
22
------ E-C coupling mechanism
Site A Site B
Halothone ( + ) Caffeine (+)
Basal twitch
Caffeine-potentiated twitch 
Halothane-potentiated twitch
Dantrolene-attenuated twitch 
Dantrolene plus caffeine 
Dantrolene plus halothone
T-tubole
Dontrolene (-)t
_ •« • ■ ■ ■ ■ ■ ■ ■ ■ ■  - . 0  ■ ■ ■ ■ ■ ■ ■ ■ » ■  ^
................. o is s h m ii*— 5.......... .  o§0 : s: : k s : : s — -
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Sarcoplasmic reticulum
Figure 2.5 Drug interactions with the E-C coupling 
The E-C coupling mechanism is proposed to consist of at 
least two sites. The signal produced at Site A is 
transmitted through Site B. Signal produced at Site B 
causes release of calcium from the SR for production 
twitch tension response. The amount of signal produced 
at Site B is proportional to that released from Site A. 
Caffeine potentiates any signal at Site B, while at 
Site A halothane is agonistic and dantrolene sodium is 
antagonistic. (From Nelson and Denborough, 1977)
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act at a site proximal to the site of action of
dantrolene sodium.
Destruction of the T-tubular system by
glycerination (Eisenberg and Eisenberg, 1968) and use 
of deuterium oxide (D20) to inhibit E-C coupling have 
both been shown to inhibit in vitro drug-induced 
contractures in MHS muscle(Okumura, Crocker and 
Denborough,1980). This evidence suggests that the 
effect of the drugs is on the sarcolemma or in the
t-system, thus further implicating the E-C coupling 
mechanism.
The temperature dependence of drug-induced
contractures in MHS muscle has been used as further
evidence to support the view that the E-C coupling 
mechanism is the site of the primary abnormality in MH 
(Sullivan and Denborough, 1981). The decreased
contractures found in MHS muscle on reducing the 
temperature from 37°C to 25°C suggested that the 
hypersensitive step coupling excitation to subsequent 
calcium release has been dissociated, and it was 
proposed that this site is localised in the t-tubule 
and the sarcoplasmic reticulum.
2.2.3 Sarcoplasmic Reticulum
Since calcium is released into the myoplasm from 
the SR, and since a MH crisis appeared to be caused by 
an excessively high concentration of calcium in the 
skeletal muscle myoplasm (Denborough, 1979; Gronert,
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1980) it seems possible that the primary MH defect 
could be in the sarcoplasmic reticulum (SR). The normal 
function of the SR is to accumulate calcium against a 
concentration gradient during relaxation, and then 
passively release calcium into the myoplasm during 
contraction. However, experiments designed to study the 
calcium uptake and release by SR have produced 
conflicting results and as yet no definite abnormality 
in this mechanism has been detected.
The more recent findings in this area have
continued to be at variance. Blank, Gruener, Suffecool
2 +and Thompson (1981) reported no difference in Ca 
uptake or release between SR isolated from MHS and 
control human muscle. It was further shown that 
halothane had a similar effect on SR from both types of 
muscle. The same type of study in porcine MH was 
reported to "demonstrate unambiguously that the SR from 
skeletal muscle of susceptible swine, when compared 
with SR from normal swine, has diminished ability to 
transport calcium and to retain accumulated calcium" 
(Gronert et al.,1979).
Britt and co-workers reported a decreased calcium 
uptake by SR from MHS human muscle (Britt, Kalow, 
Gorden, Humphrey, and Rewcastle, 1973) while in MHS 
swine muscle the SR showed an increased calcium uptake 
when compared with control muscle (Britt, Endrenyi, 
Barclay and Cadman, 1975).
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The only point on which all groups seem to agree is 
that, if there is a difference between MHS and normal 
SR, it is unable to fully explain the etiology of MH, 
nor can the effect of halothane account for its 
triggering action.
2.2,4. Energy Metabolism and MH
As discussed earlier, ATP is the primary source of 
energy for the contractile apparatus in skeletal 
muscle, while phosphocreatine is the major
energy-storage molecule. The role of ATP in the
development of a MH crisis is two-fold. It is utilised 
in the hypercontractility observed when MH is triggered 
and it is evident in the rapid increase in temperature 
which characterises MH.
Increased metabolism only appears to occur during a 
fulminant episode of MH. Resting metabolic rates have 
been shown to be similar in both control and MHS humans 
(Campbell, Ellis and Evans, 1981). This complex series 
of experiments studied muscle at rest, after exercise 
and after eating, with no significant difference being 
found between MHS and control. In contrast to this , 
MHS swine were reported to have resting metabolic rates 
ten times higher than normal (Williams, Houchins and 
Shanklin, 1975), however careful analysis of this paper 
indicates that the pigs had developed stress-induced 
fulminant MH. Hence, the ten-fold increase was not a 
resting metabolic rate. This is supported by the 
demonstration that substrate cycling of
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fructose-6-phosphate is accelerated in pigs which have 
developed MH (Clark, Williams, Pfiefer, Bloxham, 
Holland, Taylor and Lardy, 1973).
Increased heat production could also be attributed 
to the massive increase in circulating catecholamines 
(Hall, Lucke and Lister, 1975), which act by both a 
direct calorigenic effect and by causing peripheral 
vasoconstriction, thus reducing peripheral heat-loss.
The report that a family susceptible to MH has a 
muscle adenylate kinase (AK) deficiency (Schmitt, 
Schmidt and Ritter, 1974) together with the finding 
that AK has a specific binding site for halothane 
(Sachsenheimer, Pai, Shulz and Shirmer, 1977) has led 
to the proposal that a deficiency of AK may play a 
central role in the development of MH (Schmidt, 
personal communication, 1979). However a subsequent 
study has shown no generalised AK deficiency in MHS 
humans or swine (Marjanen and Denborough, 1982a). 
Further work was unable to detect any significant 
difference in the structure of AK from MHS and control 
swine (Mar janen, Shaw and Denborough, 1982 ), nor was 
the effect of halothane on AK activity significantly 
different in MHS porcine muscle (Marjanen and 
Denborough, 1982b).
The in vitro contracture response of muscle to 
halothane has been shown to be dependent on the type of 
muscle used in the experiment and it is proposed that 
this dependence is a function of the contractile and
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biochemical profile as dictated by fibre type 
differentiation (Nelson and Schochet, 1982). Trapezius 
muscle (with equal proportions of type 1 and type 2 
fibres) produced a significantly greater contracture 
when exposed to halothane than gracilis muscle 
(predominantly type 2 fibres). "Consequently, MH may be 
a feature of type 1 muscle fibres ....However, further 
experiments are necessary to determine if MH 
inheritance is limited to muscle composed predominantly 
of type 1 myofibres" (Nelson and Schochet, 1982).
2.3 SUMMARY
It appears that MH is caused by an inherited defect 
in the skeletal muscles of susceptible individuals. 
While it would be impossible in a work such as this to 
address all the possibilities proposed as the defect, I 
have attempted to investigate a number of facets of 
muscle function and MH.
In this way it is hoped that the actual muscle 
lesion can be more precisely defined, leading to a 
better understanding of the syndrome.
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CHAPTER 3 - DIAGNOSIS OF MALIGNANT HYPERPYREXIA
3.1 INTRODUCTION
In chapter 1 the need for further study of the 
current methods used in the diagnosis of MH
susceptibility was explained. In this chapter, each of 
the current diagnostic tests is described, and an
attempt is made to assess the degree of confidence 
which may reasonably be placed on each.
3.2 SCREENING FOR MALIGNANT HYPERPYREXIA
3.2.1 Creatine phosphokinase(CPK)
Elevations in the resting levels of serum CPK 
provided the first direct evidence associating MH 
susceptibility with an underlying disease of muscle 
(Denborough, Forster, Hudson, Carter and Zapf, 1970b; 
Isaacs and Barlow, 1970). Originally the CPK level was 
almost the only criterion for identifying 
susceptibility to MH, however, CPK levels may be raised 
in many conditions unrelated to MH (King and Zapf, 
1972). This can lead to false positive diagnoses. There 
have also been false negative diagnoses described 
(Ellis, Clark, Modgill, Currie, Harriman, 1975). It was 
this lack of specificity (commented on by Larard, Rice, 
Robinson, Spencer and Westhead, 1972) which led to the 
development of the more specific pharmacological 
testing of skeletal muscle (Kalow, Britt, Terreau and 
Haist, 1970; Ellis, Keaney, Harriman, Sumner,
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Kyeimensah, Tyrrell, Hargreaves, Parikh and Mulroony, 
1972 ; Moulds and Denborough, 1972, 1974).
3.2.2 Isolated muscle tests
For a definitive diagnosis it is necessary to 
obtain a muscle biopsy sample on which to carry out one 
or more of the following in vitro tests, in which 
muscle contracture is measured on exposure to certain 
drugs.
Halothane - As this is one of the principal drugs 
incriminated in the induction of MH, it is an important 
drug to study in vitro. It was first shown to produce a 
contracture in muscle from patients susceptible to MH 
by Ellis et al. (1973). It is introduced to the organ
bath by passing carbogen through a vapouriser before 
bubbling through the bathing medium.
Caffeine - In 1970 it was demonstrated that muscle
taken from an individual who had recovered from an
episode of MH was abnormally sensitive to caffeine
(Kalow et al. , 1970) . This drug has long been known to
produce a contracture in frog skeletal muscle (Axelsson 
and Thesleft, 1958). The postulated mode of action of 
caffeine involves an interference with the calcium 
release and uptake by the sarcoplasmic reticulum (Weber 
and Herz, 1968). As it has also been suggested that MH 
could be due to an increase in myoplasmic calcium 
concentration (Britt and Kalow, 1970b; Denborough, 
Hird, King, Marginson, Mitchelson, Nayler , Rex, Zapf
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and Condron, 1973), it was felt that caffeine 
contracture might be used as a model for MH, and as a 
diagnostic test.
There are two conventions for quantifying the 
caffeine effect. One is to measure the contracture at a 
caffeine concentration of 2mM at 37°C (Moulds and 
Denborough, 1972), while the other is to determine the 
specific caffeine concentration which increases the 
tension of the muscle by l.Ogram at 22°C (Kalow, Britt 
and Richter, 1977) or 37°C (Britt, Endrenyi, Frodis, 
Scott, Kalow, 1980)
Caffeine-Halothane - this is a similar test to the 
previous one, except that the muscle is exposed to 1% 
halothane in carbogen throughout the addition of 
increasing concentrations of caffeine (Britt, 1979b; 
Britt et al., 1980a).
Potassium chloride - The use of KC1 as a diagnostic 
test arose from a study of the effect of depolarisation 
on the sarcolemmal membrane. The study showed that 80mM 
KC1 caused a large contracture in MHS muscle, whereas 
in control muscle it usually gave no contracture, or at 
most, a short, sharp contracture (Moulds and 
Denborough, 1974a) . It has been used routinely in our 
laboratory to assist in the diagnosis of MH 
susceptibility.
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Succinylcholine - Although confirmed as a 
triggering agent for MH in vivo, there have been 
conflicting reports about the in vitro muscle 
contracture response using succinylcholine. Our 
laboratory consistently reports a contracture when MHS 
muscle is exposed to succinylcholine (Moulds and 
Denborough, 1974b; Okumura et al., 1979), while other 
groups have not observed this response (Kalow et al., 
1977). An attempt to resolve these conflicting results 
has been made.
Typical tracings for each of the tests described 
above are illustrated in Figure 3.1.
An analysis of the reliability of each of these 
tests and the ability of the test to differentiate 
between susceptible and non-susceptible individuals and 
animals has been made and the results are described.
3.3 METHODS
Muscle specimens for these experiments were 
obtained from both humans and swine. Different 
anaesthesia was used for the two species, but the 
method of obtaining the muscle was essentially the
same.
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Figure 3.1 Contracture responses used for MH diagnosis 
Typical contracture responses of control and MHS muscle 
to 3% halothane, 2mM caffeine, 80mM KCI and 0.4mg/ml 
Anectine. The lower tracing is the response of control 
muscle and the upper tracing is the response of MHS
muscle.
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3,3-1 Anaesthesia
Humans were first premedicated with neuroleptic 
drugs followed by either local anaesthesia with 2% 
procaine administered subcutaneously, or general 
anaesthesia using neurolept - analgesia, d-tubocurarine 
and nitrous oxide. Pigs were premedicated with the 
neuroleptic drug, Stresnil (4'-fluor-4-[4-(2-pyridyl)- 
1-piperazinyl]butyrophenone), following which 
anaesthesia was induced with thiopentone 6-8 mg/kg. 
Tracheal intubation allowed anaesthesia to be 
maintained with 66% nitrous oxide in oxygen, 
supplemented by thiopentone.
3.3.2 In vivo techniques
The in vitro results pointed to the desirability of 
clarification by in vivo experiments. The standard 
procedure used in in vivo tests was as follows:
Anaesthesia was induced using 3% halothane 
administered by means of a face mask covering the snout 
of the pig. After 30 - 60 seconds, when the animal was 
subdued, temperature was monitored using an electronic 
rectal thermometer. If no sign of rigidity or elevated 
temperature could be detected after 30 minutes of 3% 
halothane, an intravenous injection of succinylcholine 
(50mg) was given. Respiration was assisted for up to 30 
minutes, until the animal was able to maintain its own 
breathing. Temperature was continually monitored, 
together with muscular flaccidity. At any sign of
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temperature rise or rigidity, the supply of halothane 
was discontinued and therapeutic treatment, including 
intravenous infusion of dantrolene sodium and
bicarbonate, and external cooling, was instituted.
3.3.3 Surgical techniques
The methods used were essentially those described 
previously (Moulds and Denborough, 1974a). Biopsy 
specimens were taken from the vastus lateralis of 
humans or the gracilis muscle of pigs. The samples (4cm 
long, 1cm wide, 0.5cm thick) were clamped, dissected
from the bulk muscle and placed immediately into a 
muscle buffer at 37°C bubbled with 5% carbon dioxide in 
oxygen (carbogen). The composition of the muscle buffer 
was as follows: 121mM NaCl, 5.4mM KC1, 3.5mM CaCl^,
1.2mM MgS04, 1.2mM NaH2PC>4, 15mM NaHCC>3, 11.5mM 
d-Glucose. Preparations of the muscle, approximately 
2.5cm long and 2mm in diameter, were tied at both ends 
to small metal rings. These were mounted vertically
between a fixed glass rod at the base and a Watson
Victor force transducer. The whole assembly was then 
lowered into an organ bath containing 25 mis of muscle 
buffer at 37°C and continuously bubbled with carbogen. 
The signal from the force transducer was amplified with 
a San-EI 6M51 Strain Amplifier and recorded
continuously on a Perkin-Elmer 56 Chart Recorder. The 
viability of each preparation was confirmed using five 
30V electrical stimuli. Any muscle which did not 
respond with a twitch of greater than 0.75 grams was
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discarded. Figure 3.2 shows the steps involved.
3.3.4 Preparation and addition of drugs
Halothane was administered by passing carbogen 
through a calibrated Dragewick vapouriser containing 
thymol-free halothane supplied by I.C.I.
Caffeine was added by syringe from a stock lOOmM 
solution of caffeine from Sigma Chemical Company. The 
solution was freshly prepared each day by dissolving 
the drug in muscle buffer.
KC1 was added by syringe from a stock 4M solution 
in muscle buffer, which was also prepared each day.
Succinylcholine was obtained from a number of 
sources which are specified in each experiment. 
Anectine is a 50mg/ml solution of succinylcholine 
supplied by Wellcome in 2ml ampoules. Scoline is a 
similar preparation from Glaxo Pharmaceutials. Fresh 
solutions of succinylcholine (Sigma) in muscle buffer 
were also prepared. Solutions of the preservatives used 
by the drug companies were prepared at a concentration 
equal to that used in Anectine and Scoline.
Figure 3.2 Methods used for in vitro pharmacology
A. A clamp of muscle as is obtained from either humans 
or swine.
B. Two examples of the fibre bundle preparations, with 
metal rings attached, that are used for tension 
studies.
C. The organ bath with force transducer mounted above.
D. The pre-amplifier, recorder and electrical 
stimulator used in the experiments.
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3.4 THE SUCCINYLCHOLINE DILEMMA
3.4.1 Results
Conflicting results from various laboratories were 
partially resolved by the observation that all of the 
commercial preparations of succinylcholine did not give 
the same results. Typical contractures obtained using 
Anectine, Scoline and Sigma succinylcholine, as well as 
the preservatives 4-chloro-m-cresol and benzyl alcohol, 
are illustrated in Figure 3.3. Whereas Anectine, a 
product of Wellcome, consistently caused MHS muscle to 
contract at a concentration of 1.12mM, Scoline (Glaxo) 
failed to induce a contracture at 1.12mM but usually 
did so at a concentration of 7-9mM. Dose response 
curves for each of these drugs are shown in Figure 3.4. 
This result led to a detailed study of each of these 
preparations, together with pure succinylcholine 
(Sigma) and the preservatives used in the Wellcome and 
Glaxo preparations. The results can be compared in two 
ways- either, by measuring the tension obtained when a 
particular concentration of the drug is added, or, by 
measuring the concentration of the drug required to 
increase the muscle tension to a predetermined level. 
Tables 3.1 and 3.2 present the results obtained with 
MHS and control porcine muscle. Table 3.1 compares the 
contracture obtained using 1.12mM pure succinylcholine 
with that obtained using an amount of preservative 
equivalent to that added in the pharmaceutical
preparation. The concentrations of each of these drugs
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Figure 3.4 Dose response curves for different 
preparations of succinylcholine 
Dose response curves for contractures induced in MHS 
muscle by Anectine ■ , 4-chloro-m-cresol □ ,
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required to produce a contracture of 0.3 grams are also 
shown in Table 3.2. Since the first consideration for 
the use of any human muscle obtained was the diagnosis 
of susceptibility to MH, and because it was not 
feasible to obtain large quantities of muscle from 
humans, it was not possible to carry out a complete set 
of experiments, similar to those described for swine. 
However, results which are presented in Table 3.3 
indicate that MHS human muscle demonstrates similar 
trends to those of MHS porcine muscle.
From these results it was apparent that the 
in vitro response seen in MHS muscle was caused by the 
preservative, rather than by the succinylcholine. The 
next question arising was whether the development of MH 
in vivo was related to the type of preservative used. 
Two MHS pigs were anaesthetised with thiopentone and 
nitrous oxide and then given an injection of pure 
succinylcholine (Sigma, 100mg). The typical symptoms of 
MH, vis. high temperature and muscle rigidity, quickly 
became apparent and both pigs died.
3.4.2 Discussion
Anectine consistently produced a contracture in MHS 
muscle from both swine and humans at a concentration of 
0.4mg/ml, which is a 1.12mM solution of 
succinylcholine. Neither Scoline nor pure 
succinylcholine (Sigma) produced a contracture at this 
concentration. The contracture due to Anectine was 
significantly different (p<0.001) to that due to pure
200ul Scoline added - Final 
concentration 
in bath was 1.12 mM succinylcholine plus
1.12 mM benzyl alcohol
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3.3: 
Drug-induced contractures 
in control and MHS human skeletal muscle
using different preparations of succinylcholine
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succinylcholine, but was not significantly different to 
that produced by the preservative, 4-chloro-m-cresol, 
at the concentration present in Anectine.
The results for specific concentrations are shown 
in Table 3.2. Anectine and 4-chloro-m-cresol were the 
only drugs which caused a 0.3g contracture in control 
muscle, and they did so when the concentration of the 
4-chloro-m-cresol was 0.2mM, irrespective of the 
presence of succinylcholine. The other drugs were 
tested up to a concentration of 36mM, but no 
contracture was observed. MHS swine muscle gave 0.3g 
contractures with Anectine, 4-chloro-m-cresol, Scoline 
and benzyl alcohol. Pure succinylcholine failed to 
induce a contracture at 36mM, 32 times the 
concentration of Anectine-derived succinylcholine 
required to produce a 0.3g contracture. There was no 
significant difference in the concentration of pure 
4-chloro-m-cresol and of 4-chloro- m-cresol in Anectine 
which were required to produce the same degree of 
contracture. The results show a significant difference 
between Scoline and benzyl alcohol (p<0.05), but both 
drugs produced a significantly greater contracture than 
pure succinylcholine. The difference between Scoline 
and its preservative might be due to inter-pig or 
intra-pig variations, or possibly due to the 
concentration of preservative in Scoline being higher 
than stated on the leaflet included with the drug.
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However, even allowing for this one discrepancy, 
the results clearly indicate that contracture of MHS 
muscle is not due to the succinylcholine alone and is 
dependent on the presence of the preservatives used in 
the pharmaceutical preparations. It has been 
established that reports of succinylcholine- induced 
contractures in MHS muscle used Anectine in the 
experiments (Moulds and Denborough, 1974b; Personal 
communication, M.A.Denborough, 1982).
While this study has explained the "puzzling 
results" referred to in a recent review of MH (Gronert, 
1980), it has also led to a better understanding of the 
in vitro action of succinylcholine in MHS humans and 
swine.
Succinylcholine is a depolarizing muscle relaxant 
which acts on the acetylcholine receptors in the motor 
end-plate region of the muscle cell. Its action is more 
prolonged than that of acetylcholine because of a 
slower rate of metabolism. The in vitro action of
succinylcholine on MHS muscle could not be via the
motor end-plates since these do not exist in the
bundles of muscle fibres used for these experiments 
(Gronert and Theye, 1975). Chronically denervated 
muscle shows an increased sensitivity to acetylcholine 
(Rosenblueth and Luco, 1937) and to succinylcholine 
(Thesleff, 1974), due to the development of 
acetylcholine receptors throughout the muscle membranes 
(Axelsson and Thesleff, 1959) but as acetylcholine does 
not induce contracture in MHS muscle, widespread
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acetylcholine receptors cannot explain the 
succinylcholine-induced contractures (Okumura et al., 
1980). Okumura et al. go on to postulate that, as 
succinylcholine does not appear to act on nicotinic 
acetylcholine receptors, it may induce MH by 
interacting with a defect in the sarcolemma or 
t-system. The results presented in this chapter show 
that succinylcholine does not cause a contracture in 
MHS muscle and so the postulate of Okumura et al. is 
not valid.
This raises the possibility that the in vivo action 
of succinylcholine could be at the level of the motor
end-plate. It is proposed that the fasciculations,
characteristic of Phase I block by succinylcholine
(Collier , 1975; Durant and Katz, 1982), result in a
release of calcium into the myoplasm of the muscle. The
increased level 2+of Ca could act as the trigger for
MH. If the fasciculations are prevented by
pre-treatment with d-tubocurarine, then succinylcholine 
does not induce MH (Harrison, 1973; Hall, Lucke and 
Lister, 1976), further supporting the proposal that 
succinylcholine induced MH is a result of the normal 
action of succinylcholine.
<
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3.5 COMPARISON OF TESTS
3.5.1 Results
An analysis of the contracture response of control 
human muscle to 3% halothane, 2mM caffeine, 80mM KC1 
and 0.4mg/ml Anectine is given in Table 3.4 and
appendix A.l. From these results each of the drugs was 
assigned a contracture value which differentiated a 
positive response from a control response. This value 
was the mean, plus 2 standard deviations. The values 
for the four drugs were 0.25g for halothane, 0.35g for 
caffeine, 0.9g for KC1 and 0.2g for Anectine.
Six tests were then defined for study: the muscle
contracture response to 3% halothane, 2mM caffeine, 
80mM KC1 and 0.4mg/ml Anectine, the specific
concentration of caffeine in the presence of 1% 
halothane required to produce a lg contracture and the 
serum CPK of the patient. A series of 85 patients,
suspected of being susceptible to MH, were biopsied and 
the response to the six tests was measured. The
correlation between the tests was assessed in the 
following way: Each of the four drugs, halothane,
caffeine, KC1 and Anectine was used, in turn, to 
classify the muscle as positive or negative. Based on 
this classification the response to each of the other 
five tests was studied to determine whether or not it 
gave the same diagnosis. The means and standard
deviations of the response to each of the five tests
for patients classified as positive or negative by one
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TABLE 3.4 Response of control human muscle to the drugs 
3% halothane, 2mM caffeine, 80mM KC1 and 
0.4mg/ml Anectine
DRUG N
3% halothane 28 
2mM caffeine 43 
80mM KC1 11 
0.4mg/ml Anectine 11
CONTRACTURE
MEAN S. D. RANGE
0.07 0.09 0.00 - 0.37
0.06 0.15 0.00 - 0.67
0.24 0.35 0.00 - 1.21
0.06 0.07 0.00 - 0.16
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of the four drugs are given in Table 3.5. The 
correlation between responses is presented graphically 
in Figures 3.5, 3.6, 3.7 and 3.8. The first histogram 
in each figure shows the distribution of responses for 
the drug used to categorise the patients, while the 
distribution of responses to each of the other five 
tests is depicted in the remaining histograms. The 
shaded columns indicate the patients whose muscle 
showed a positive response to the classification drug.
3.5.2 Discussion
Each test will be discussed separately and then 
some final conclusions will be drawn.
Halothane : 3% halothane induced a significantly
greater contracture in muscle shown to be positive by 
2mM caffeine, 80mM KC1 and 0.4mg/ml Anectine. Also 
muscle which gave a positive response to 3% halothane 
was significantly more sensitive to caffeine, KC1, 
Anectine and to caffeine in the presence of 1%
halothane, and was also associated with a significantly 
higher serum CPK.
The histograms in Figure 3.5 show that muscle which 
gave a negative response to halothane gave no
contracture with other drugs in the majority of
patients. There were five patients classified as
negative by halothane whose muscle gave a positive 
caffeine response, indicating that halothane testing 
alone would have missed five of the 41 patients who
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TABLE 3.5 Analysis of contracture response of muscle to various 
tests when the muscle has been classified on the basis of
another drug
Drug used to
categorise Halothane Caffeine KC1 Anectine
Number -ve 40 57 72 62
Number +ve 48 27 12 22
HALOTHANE
-ve patients - 0.38(0.50) 0.51(0.66) 0.44(0.57)
+ve patients - 2.12(2.63) 3.29(3.32) 2.25(2.79)
P <0.0001 <0.0001 <0.0001
CAFFEINE
-ve patients 0.11(0.30) - 0.22(0.43) 0.16(0.34)
+ve patients 0.67(0.85) - 1.53(0.94) 1.09(0.95)
P <0.0001 — <0.0001 <0.0001
KC1
-ve patients 0.12(0.25) 0.08(0.19) - 0.09(0.16)
+ve patients 1.03(1.99) 1.67(2.35) - 1.99(2.46)
P <0.005 <0.0001 — <0.0001
ANECTINE
-ve patients 0.15(0.39) 0.07(0.19) 0.13 (0.32 ) -
+ve patients 0.50(0.79) 0.82(0.89) 1.33(0.93) -
P <0.01 <0.0001 <0.0001 —
HALOTHANE/CAFF
-ve patients 1.12(0.59) 1.06(0.54) 0.86(0.61 1.02(0.63)
+ve patients 0.37(0.26) 0.44(0.52) 0.32(0.16) 0.39(0.27)
P <0.005 <0.05 N. S. <0.05
CPK
-ve patients 47(25)
Specific activity (i/U) 
98(219) 93(198) 93(217)
+ve patients 136(246) 89(74) 108(97) 99 (185)
P <0.05 N. S. N. S. N. S.
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were susceptible to MH on the basis of halothane and 
caffeine tests.
Caffeine : 2mM caffeine induced a significantly
greater contracture in muscle which gave positive 
contractures to 3% halothane, 80mM KC1 or 0.4mg/ml 
Anectine. Also muscle which gave a positive response to 
2mM caffeine produced a significantly larger 
contracture on exposure to halothane, KC1, Anectine, 
and caffeine in the presence of 1% halothane. There was 
no significant increase in the serum CPK of patients 
with a positive 2mM caffeine response. The histograms 
in Figure 3.6 illustrate that patients categorised as 
positive or negative on the basis of halothane, KC1 or 
Anectine show a larger overlap in the response of their 
muscle to 2mM caffeine, than was observed with 
halothane responses of patients classified on the basis 
of muscle response to caffeine, KC1 or Anectine. Twenty 
three patients who gave negative caffeine results were 
shown to be susceptible by their muscle response to 
halothane. However, caffeine testing was able to show 
four patients to be susceptible, who would not have 
been diagnosed by the use of halothane alone.
KC1 : The contracture produced by 80mM KC1 was
significantly larger in muscle which gave a positive 
response with any of the other drugs, indicating that 
MHS muscle is more sensitive to depolarisation than
control muscle.
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Since the response of control muscle to 80mM 
caffeine was so varied, the threshold contracture used 
for the purposes of diagnosis (0.9g) was such that many 
patients, shown to be positive by halothane and 
caffeine, gave negative responses to KC1. However, the 
mean KCl-induced contracture in muscle shown to be 
negative by halothane, caffeine and succinylcholine was 
significantly smaller than the mean contracture 
produced by KC1 in the control group.
In another study, six pigs, the muscle from which 
showed a 0.5-1.0g response to 80mM KC1, but not to any 
of the other drugs, were challenged with halothane and 
succinylcholine anaesthesia. There was no evidence of 
any of the symptoms of MH in these pigs, suggesting 
that they were not susceptible to MH (Crocker , 
Sullivan, Galloway and Denborough, unpublished 
results).
Anectine : As has been discussed previously, the
in vitro response to this drug is due to the 
preservative, rather than to the succinylcholine, but 
it could still be a valid diagnostic test if able to 
differentiate between control and MHS muscle.
Muscle classified as positive on the basis of its 
response to any of the drugs, 3% halothane, 2mM 
caffeine and 80mM KC1 produced a significantly larger 
contracture on exposure to 0.4mg/ml Anectine. Also 
muscle classified on the basis of 0.4mg/ml Anectine was 
significantly more sensitive to any of these drugs.
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However, the histograms (Figure 3.8) show that there is 
a marked overlap of responses when compared with 
halothane or caffeine. Twenty five patients classified 
as positive by halothane would have been diagnosed 
negative on the basis of the contracture response to 
Anectine.
1% halothane/caffeine : When compared to 3% 
halothane, 2mM caffeine or 0.4mg/ml Anectine, this 
combination of drugs required a significantly lower 
specific concentration to give a lg contracture in 
muscle classified as positive. Muscle classified by its 
response to KC1 showed no significant difference in its 
response to halothane/caffeine.
The histograms presented show that muscle, which 
gave no response to halothane, caffeine, KC1 or 
Anectine often produced a similar response to 
halothane/caffeine as muscle which did respond to 
halothane, caffeine, KC1 and Anectine. Thus, this test 
was unable to satisfactorily differentiate between 
normal and MHS individuals.
Serum CPK : The values for serum CPK were 
significantly higher in patients whose muscle gave a
positive response to halothane. If any of the other
tests were used to categorise patients, then the
resulting two groups of patients did not have
significantly different CPK values. The distribution of 
CPK values was such that there was a large overlap 
between patients classified as positive or negative on
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the basis of halothane, caffeine, KC1 or Anectine. 
Therefore, the use of CPK values as a diagnostic 
criterion would lead to both false positives and false 
negatives.
3.5,3 Protocol for testing MH susceptibility
Figure 3.9 is a flow chart which suggests the steps 
which should be undertaken to diagnose a family for 
susceptibility to MH. It assumes a propositus, known to 
have MH because of an anaesthetic reaction, or previous 
d iagnosis.
An initial CPK estimation may be helpful to 
determine which of two parents should first be 
biopsied.
Halothane contracture is the most reliable in vitro 
test for MH susceptibility. It most clearly
differentiates between a negative and a positive 
response, and the degree of overlap based on diagnosis 
by other drugs is less than for any other test.
Caffeine is also reliable and will select any of 
the patients who are susceptible to MH, but whose 
muscle did not respond to halothane. A response to 
0.4mg/ml Anectine can help to confirm susceptibility, 
but a positive Anectine contracture has not yet been 
seen in muscle which failed to respond to either 
halothane or caffeine. A KC1 induced contracture,
alone, would not be sufficient to indicate MH
susceptibility, but this test can also be used for
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Propositus
Parents
Investigate family history 
CPK determination
to suggest which parent should first be biopsied
Riopsy
Response to 3% halothane and 2mM caffeine 
This should select any MHS patients
Response to 0.4mg/ml Anectine 
Can be used to confirm diagnosis
Response to 80mM KC1 
A positive response to this test alone 
does not indicate MH susceptibility
Figure 3.9 A suggested protocol for the determination
of susceptibility to MH
60
confirmation of diagnosis.
In conclusion, it should be stated that any test 
should be carried out in duplicate, as single 
preparations of muscle can give false negative 
contracture responses for reasons which remain obscure.
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CHAPTER 4 - MEMBRANE POTENTIAL STUDIES
4,1 INTRODUCTION
It has previously been suggested that the primary 
lesion in MHS muscle may occur at the level of the 
plasma membrane or sarcolemma, an hypothesis based on 
an observed depolarization of the sarcolemma caused by 
halothane (Gallant, Godt and Gronert, 1979; Galloway, 
Bornstein and Denborough, 1980). A conflicting result 
in the literature reports that halothane has no effect 
on the resting membrane potential (RMP) of muscle 
isolated from MHS swine (Bradley, Ward, Murchison, Hall 
and Woolf,1973).
Results reported in this chapter ascribe the 
discrepancy in previous results to the temperature at 
which the experiments were carried outf and correlates 
this to an observed difference in the contractile 
response of MHS muscle as a function of temperature 
(Nelson, Bedell and Jones, 1975; Sullivan and 
Denborough, 1981-) .
It is further suggested that both the experiments 
cited previously (Gallant et al. , 1979; Galloway et
al., 1980) and further results presented in this 
chapter show that the primary lesion is not necessarily 
at the level of the sarcolemma but could be distal to 
it. The depolarization could be caused by an increase 
in the concentration of calcium in the myoplasm.
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4.2 METHODS
4.2.1 Animals and Surgery
Experiments were carried out on both control and 
MHS porcine muscle. Susceptibility to MH was determined 
using gracilis muscle as described in Chapter 3.
Membrane potential studies require the use of an
intact muscle rather than the cut fibre preparation
obtained from the gracilis. The outer intercostal
muscle was chosen because it was a short muscle (2-3cm)
and had previously been shown to be affected in MHS
swine (Anderson, Lipicky and Jones, 1978). The muscle
t h t hwas removed from the 5 or intercostal space under
nitrous oxide/thiopentone anaesthesia (see section 
3.3.1). After the intercostal muscle and the ribs had 
been exposed, 2-4cm of external intercostal muscle were 
removed, together with the tendons and a small piece of 
bone, and immediately placed into 37°C muscle buffer 
and gassed with carbogen. The fine dissection was 
carried out in a bath of gassed muscle buffer at 25°C 
under a lOx magnification stereomicroscope. The muscle 
was kept under tension by pinning the tendons to a 
layer of silicone elastomer (SYLGARD 184 - Dow Corning) 
in the base of the bath. In this way excess connective 
tissue and damaged muscle fibres could be removed to 
yield a preparation of about 400 fibres (40 fibres wide 
by 10 fibres thick) which was then ready for the 
electrophysiological measurements. The time between 
removal from the pig and the start of recording was
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typically 90 min.
4.2,2. Electrophysiological Recording
The muscle preparation was pinned to the base of a 
25ml bath maintained at a constant temperature by a 
Braun Thermomix circulating water bath (Figure 4.1A). 
Pre-heated, carbogen-saturated muscle buffer flowed 
into the bath at 10 ml/min and the level was maintained 
by aspiration. Electrical isolation was achieved by the 
use of a 70cm x 55cm x 50cm galvanised steel Faraday 
cage opened at the front . The organ bath, microscope 
and micromanipulator were inside the box, while the 
buffer reservoir, circulating water bath and vacuum 
pump for aspiration were outside (Figure 4.IB).The 
ingoing and outgoing muscle buffer passed through drip 
chambers and the heating water was earthed as it passed 
through the side of the Faraday cage. The cage was 
placed on a terracotta slab supported by brick pillars 
and mechanically isolated by polyurethane foam. This 
prevented any external vibrations being transmitted to 
the muscle.
Micro-electrodes, pulled from 3mm outer diameter 
glass tubing and filled with 3M KC1, had tip diameters 
of about 1pm and electrode resistances of between 10 
and 20Mft . These were coupled via an Ag-AgCl reversible 
half-cell to a miniature gold-plated WPI KS-700 probe 
incorporating the pre amplifier. This in turn was 
connected to the main amplifier (WPI KS —700 Dual
Microprobe System) which was located outside the
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Faraday cage. A second Ag-AgCl half-cell was used to 
return the ground electrode to the muscle bath. The 
KS-700 system has a digital readout which was used for 
measuring membrane potentials. A cathode-ray 
oscilloscope was used to ensure that electrical noise 
was within the allowable limits of 0.5mV.
The glass micro-electrode and probe assembly was 
mounted on a Prior Micromanipulator, such that the tip 
of the electrode could be moved vertically through the 
muscle preparation.
4.2.3 Determination of resting membrane potential
At the beginning of each experiment and after 
treatment of the muscle, the resting membrane potential 
(RMP) was determined by averaging the membrane 
potential of 25 - 30 cells. Each experiment was carried 
out in 2 or more muscle preparations and the 
statistical significance of any observed effects was 
estimated by unpaired Student's t-tests.
4.2.4 Drug treatment of muscle
Drugs were added to the reservoir of muscle buffer. 
Halothane was introduced by passing carbogen through a 
calibrated Dragewick vapouriser containing thymol-free 
halothane. Caffeine was added by syringe from a stock 
of lOOmM solution in muscle buffer.
Figure 4.1 Apparatus for intra-cellular recording
of resting membrane potentials
A. Heated organ-bath with muscle preparation pinned in 
place. The electrode and preamplifier can be seen above 
the bath
B. Faraday cage showing the organ-bath, the microscope 
and the micro-manipulator with probe assembly
65
66
4.3 RESULTS
4,3.1 Effect of halothane and temperature
Resting membrane potentials were measured before 
and after exposing the muscle to 3% halothane. This was 
done at both 25°C and 37°C in control and MHS porcine 
muscle. If a change was observed at any stage of an 
experiment, the stimulus which caused the change was 
reversed. If any change could not be reversed, the 
experiment was discarded. This ensured that any 
depolarization was not simply due to muscle fatigue.
The results of the experiments at 37°C and 25°C are 
given in Figures 4.2 and 4.3 respectively. There was no 
significant difference between MHS and control muscle 
when measured at either temperature, but there was a 
significant depolarisation (p<0.001) in both control 
muscle and MHS muscle when it was cooled from 37°C to 
2 5°C.
At 37°C halothane caused a significant 
depolarization (pCO.OOl) in MHS muscle only, while at 
25°C neither MHS nor control muscle was affected by
halothane.
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Figure 4.2 Effect of halothane on the RMP of control 
and MHS muscle at 37°C
The resting membrane potentials of control and MHS 
porcine intercostal muscle before [ ] and after 
treatment with 3% halothane are shown.
* * * p<0.001
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CONTROL
Figure 4.3 Effect of halothane on RMP of control 
and MHS muscle at 25°C
The resting membrane potentials of control and MHS
□ and afterporcine intercostal muscle before 
treatment with 3% halothane at 25°C are shown. The 
lines above the columns indicate the RMP at 37°c.
No significant difference was found for either type of
muscle at 25 C.
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4.3.2 Effect of 2mM caffeine
At a concentration of 2mM, caffeine does not cause 
a contracture in control muscle, while MHS human and 
MHS porcine muscle both contract when exposed to 2mM 
caffeine (Kalow and Britt, 1970; Okumura et al.,1979).
Figure 4.4 shows the effect, at 37°C, of low
concentrations of caffeine on the RMP of intercostal
muscle from control and MHS swine. The amount of
caffeine added to the MHS muscle was equivalent to the 
concentration required to cause a 0.3g or greater 
contracture in a preparation of gracilis muscle from 
the same pig. For control experiments, a caffeine 
concentration of 2mM was used, this being the maximum 
for any experiments on MHS muscle. These results show a 
significant depolarization in MHS muscle which was not 
observed in control muscle. Similar experiments at 25°C 
showed that 2mM caffeine did not depolarize intercostal 
muscle from MHS swine as shown in Figure 4.5.
4.3.3 Effect of 8mM caffeine
Caffeine is known to cause a contracture in normal 
muscle at a concentration of 8mM and it has been 
proposed that it does so by a direct effect on calcium 
transport across the sarcoplasmic reticulum (Weber and 
Herz, 1968). Experiments were carried out to study the 
effect of 8mM caffeine on the RMP of control 
intercostal muscle from swine. In two experiments, it 
was demonstrated that 8mM caffeine produced a 
significant (p<0.005) depolarization in control muscle.
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Figure 4.4 Effect of caffeine on RMP of control 
and MHS muscle at 37°C
The effect of increasing concentrations of caffeine on
the resting membrane potential of control A ----- A and
MHS ■--- ■ porcine intercostal muscle at 37°C is shown.
* p<0.05 ***p<0.001 n.s. not significant
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Figure 4.5 Effect of caffeine on the RMP of MHS 
muscle at 25°C.
The effect 'of ImM and 2mM caffeine on the resting 
membrane potential of MHS porcine intercostal muscle is 
shown
n.s. not significant
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4.4 DISCUSSION
The differing results concerning the depolarization 
of MHS porcine muscle by halothane may be a reflection 
of the temperature at which the experiments were 
carried out. Bradley et al. (1973), who observed no
depolarization, did not specify the temperature at 
which their experiments were conducted, but reported 
that MHS muscle did not contract on exposure to
halothane. As it has now been shown that the
contracture response of MHS muscle to halothane does
not occur at 25°C (Nelson, Bedell and Jones, 1975), it 
seems likely that the experiments of Bradley et al. 
were performed at room temperature. This could explain 
the absence of depolarization of MHS muscle when 
exposed to halothane. By comparison, the experiments of
Gallant et al. (1979) , which resulted in
depolarization, were carried out at 37°C. At this
temperature, contracture of MHS muscle in response to
halothane is known to occur (Nelson et al. , 1975).
The results reported in this chapter confirm that, 
in MHS porcine muscle, halothane has no effect on the 
membrane potential of MHS muscle at 25°C. It does, 
however, cause a small depolarization (5-10mV) of the 
sarcolemma at 37°C. This is insufficient to induce a 
contracture in normal muscle, where a depolarization of 
30mV is necessary to induce a microscopically visible 
contracture (Bryant and Anderson, 1977). In MHS fibres, 
the depolarization required is about lOmV (Bryant and 
Anderson, 1977). Gallant et al. use this latter result,
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in conjunction with the observed depolarizing effects 
of halothane on MHS muscle fibres, to propose that 
drug-induced contractures in MHS muscle are caused by 
an interaction of the drug with the sarcolemma. They 
extend this hypothesis to suggest that the primary 
lesion in MH is a plasma membrane defect (Gallant et 
al., 1979) .
The observation in the present investigation that 
2mM caffeine also results in a depolarization of the 
sarcolemma in MHS porcine muscle suggests that its mode 
of action is similar to that of halothane. The effect 
of caffeine on RMP is temperature dependent in the same 
way as halothane, 2mM caffeine has no effect on RMP at 
2 5°C.
The contracture induced in control muscle by 8mM 
caffeine has been suggested as a model for the 
hypersensitive drug-induced contractures observed in 
MHS muscle (Austin and Denborough, 1977). The 
depolarizing effect of 8mM caffeine on control porcine 
intercostal muscle is comparable to that produced by 3%
halothane or 2mM caffeine in MHS muscle. This is in
agreement with previous studies of the effect of
caffeine on the RMP of frog muscle (Axelsson and
Thesleft, 1958; Luttgau and Oetliker , 1968). The
contractile mechanism of skeletal muscle is activated 
by 8mM caffeine independently of the large membrane 
depolarization normally required for contraction 
(Axelsson and Thesleft, 1958). Caffeine-induced 
contractures are also independent of t-tubule integrity
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(Gage and Eisenberg, 1967) and external calcium 
concentration (Frank, 1960). These features can be
explained by a direct action of caffeine on the
sarcoplasmic reticulum, resulting in calcium release, 
as demonstrated by Weber and Herz (1968) . Studies of 
the potential across SR membranes indicate that an
inside-negative membrane potential could form during 
contraction. The transport of calcium may not be fully 
compensated for by the counter transport of cations, or 
only partially compensated for by the transport of
anions in the opposite direction (Beeler, 1980).
It is possible that the depolarization observed in 
control muscle exposed to 8mM caffeine, and in MHS 
muscle exposed to 3% halothane or 2mM caffeine, could 
be due to an increase in myoplasmic calcium. This is 
consistent with the theory that fulminant MH is due to 
calcium release from the SR, caused by a direct effect 
on the SR or an effect on the E-C coupling mechanism 
(Okumura et al ,.1980).
Dantrolene sodium has been successfully used in the 
treatment of MH in vivo (Harrison, 1975; Jardon, Kerr, 
Cochran and Wingard, 1976; Harrison, 1977) and it has 
also proved effective in vitro in the inhibition and 
reversal of drug-induced contractures in MHS muscle 
(Anderson et al. , 1976 , 1978; Austin and Denborough,
1977; Okumura et al., 1980). In normal muscle,
dantrolene sodium is thought to exert its relaxing 
effect by antagonising intracellular calcium release 
(Ellis and Carpenter, 1972; Ellis and Bryant, 1972; Van
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Winkle, 1976; Francis, 1978). Dantrolene sodium has 
been shown to reverse the depolarization of sarcolemma 
by halothane in MHS muscle (Gallant et al. , 1979).
Although they acknowledge the suggested mode of action 
of dantrolene sodium in normal muscle, Gallant et al. 
interpret its antagonising effect on MHS muscle as 
resulting from an effect on the sarcolemma. As the 
weight of current evidence suggests that dantrolene 
sodium acts primarily on the calcium release mechanism 
(Putney and Bianchi, 1974), it is possible that the 
depolarization of MHS muscle-by 3% halothane and by 2mM 
caffeine is a secondary effect caused by calcium
release from the intracellular stores into the 
myoplasm.
This proposal could be tested by means of an 
experiment in which the E-C coupling mechanism is 
inhibited. An attempt was made to do so, using glycerol 
treatment (Eisenberg and Eisenberg, 1968) to destroy 
the t-tubules, but, the treatment itself caused a 
depolarization so large that it was not possible to
study the effect of halothane. A better result might be 
obtained by using D^O muscle buffer, to inhibit the
process by which depolarization of the T-system is
transmitted to the SR (Kaminer, 1960). D 2 O prevents
contracture responses in MHS muscle, (Okumura et al., 
1980) presumably by inhibiting the calcium release from 
the SR. If D 2 O prevented the depolarization of the 
sarcolemma, this would suggest that the depolarization 
is caused by calcium release into the myoplasm or by
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some related process. If the sarcolemma were 
depolarized by halothane in the presence of D^O, the 
site of action of the halothane would be proximal to 
the site of action of the D^0, possibly at the level of
the sarcolemma.
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CHAPTER 5 - NUCLEAR MAGNETIC RESONANCE AND MH
5.1 THEORY OF NUCLEAR MAGNETIC RESONANCE
The aim of this presentation of NMR theory is not 
to give a full treatise on the subject, but rather a 
few principles which will help to explain the 
application of the technique to the present study. It 
is first necessary to understand some of the magnetic 
properties of the nucleus. All nuclei are charged 
particles and in some nuclei this charge "spins" on the 
nuclear axis. The angular momentum of the spinning 
charge can be described in terms of the spin number, I, 
which has the values 1/2, 1, 3/2 etc. The following
description only considers nuclei with a spin of 1/2, 
although NMR signals can be obtained from any nucleus 
with a non-zero spin. Like any moving electrical 
charge, a spinning nucleus generates a magnetic moment, 
u, and it is this property which is exploited in 
nuclear magnetic resonance. If a magnet is placed in a 
large magnetic field, it will align itself in the 
direction of that field. In the case of a nucleus with 
spin 1/2, the magnetic dipole has two orientations in 
an applied field: parallel to the field, or
antiparallel, the former orientation having slightly 
lower energy.
The other important property is that a small magnet 
spinning in an external field will actually precess 
about the axis of the field in the same way that a 
gyroscope precesses in a gravitational field. The
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precessional angular velocity, w is proportional to 
the strength of the applied magnetic field, H .
“o = Y Ho (5-1)
where y is the magnetogyric ratio, which is a constant
for any given nucleus.
Also the energy difference between the two states 
for a nucleus with 1=1/2 has been shown to be
E=hv =H0y/I =2yHQ (5.2)
and since y is directly proportional to the spin 
y= Y Ih/2tt where h is Plank's constant
then
hv = Y HQIh/Tr = y HQh/2Tr
therefore
(5.3)
v = y H0/27T (5.4)
substituting 5.1 into 5.4
v =u)o/2tt (5.5)
Hence, the frequency of radiation that causes a nucleus 
to move to a higher energy state is equivalent to its 
angular frequency and is referred to as the resonance 
frequency for the nucleus. This frequency is 
proportional to the applied magnetic field, H .
NMR is useful because the magnetic field seen by a 
particular nucleus is not H , but the sum of Hq and the 
field due to nearby nuclei and electrons. This means 
that nuclei of the same element but in different 
chemical environments (giving rise to different 
magnetic environments) have different resonance 
frequencies. The locally derived magnetic field is very 
small compared with the extremely large field of the
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NMR instrument and changes in resonance frequency are 
measured as parts per million. These changes are called
the chemical shifts and it is this property which
allows nuclei from a variety of compounds to be
identified and quantified, making it possible to study
reactions and movements of these compounds.
Originally, NMR spectra were obtained by continuous 
wave (CW) techniques. A sample was placed within the 
magnetic field and irradiated using radiofrequency (RF) 
energy. The frequency of this RF field was slowly 
varied, and when the resonance condition (Eq 5.4) was 
satisfied for the nucleus under observation, the sample 
absorbed energy and the resulting signal detected, 
amplified and recorded. In this way the resonance 
frequency of each species of a particular nucleus was 
measured.
To improve the signal-noise ratio (S/N), it is 
possible to record several spectra and add them 
together. The NMR signals will add coherently, whereas 
the noise, being random, will add as the square root of 
the number of spectra accumulated. If this is done 
using CW-NMR, the experiment, while achieving its aim, 
will take a long time, since each CW scan takes about 
200- 500 s. A thousand scans would take between 50 and 
100 h. This problem has been overcome by the advent of 
pulsed, or Fourier Transform, NMR (FT-NMR).
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If a signal at frequency F is turned on for a very 
short period of time, t s long, a range of frequencies, 
centred about F and having a bandwidth of 1/t is 
obtained. Hence, by choosing a suitably small value of 
t, it is possible to excite all nuclei of interest 
simultaneously. In the FT experiment, the sample is 
irradiated in this manner and as the system returns to 
thermal equilibrium, the energy emitted is detected, 
amplified and recorded. The spectrum . thus obtained is a 
measure of intensity as a function of time, a 
time-domain spectrum. This can be converted to a 
frequency-domain spectrum, as is produced in the CW 
experiment, by a mathematical process known as Fourier 
Transformation. The relationship between the time and 
frequency domain spectra can be expressed in the form
F (v)= f(t)exp -i t(dt) (5.6)
where F(v) is a function of frequency and f(t) is the 
corresponding function of time. This transformation is 
carried out by a small computer connected to the 
spectrometer.
Using FT-NMR a spectrum can be obtained in a time 
period between 0.1 and 10s; hence a large number of 
spectra can be accumulated and added in a relatively 
short time, enabling the S/N ratio to be increased to a 
satisfactory level.
81
5.2 P-31 NMR AND MUSCLE METABOLISM IN MH
A recent review of applications of P-NMR to the 
study of muscle metabolism provides an excellent 
introduction to this topic (Meyer, Kushmerick and
Brown, 1982). The following is an attempt to summarise 
the concepts presented and to relate them to the study 
of MH.
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Since the first reported spectra of frog muscle 
(Hoult, Busby, Gadian, Radda, Richards and Seeley, 
1974), the extent of NMR use in the study of biological 
tissue has grown rapidly. Muscle has provided an 
interesting system for such studies since it contains 
relatively large concentrations of a number of 
phosphorus compounds. These compounds are actively 
involved in the functional processes of muscle. A
spectrum of muscle contains one resonance from
inorganic phosphorus (P^), another from phosphocreatine 
(PCr) , and three resonances from ATP. The spectra can 
be used to determine relative levels of these three
compounds. In practice, it is difficult to measure 
absolute tissue concentrations, since the amount of
muscle in the detector region of the spectrometer 
cannot be determined.
More recently, NMR has been used to measure the
reaction rates in whole muscle samples. If the nuclei 
of one chemical species are magnetically perturbed by 
irradiating at its exact resonant frequency, and if 
chemical exchange takes place before nuclear relaxation
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is complete, the perturbation will be observed in the 
resonance from the second species (Forsen and Hoffman, 
1963). This technique has been used to study the 
creatine phosphokinase reaction:
ADP + PCr ^  ATP + Cr (5.7)
The y -phosphate ATP resonance was selectively 
irradiated and the PCr resonance observed. These 
experiments were used to show that the entire cellular 
contents of ATP and PCr may be considered to be in 
simple chemical equilibrium via the creatine
phosphokinase reaction (Gadian,Radda, Brown, Chance, 
Dawson and Wilkie, 1981; Meyer et al., 1982).
MH has been shown to be a muscle disorder and high 
temperatures observed during a fulminant episode of MH 
suggest that there might be a defect in muscle
metabolism. NMR has been used to study the effect of 
halothane and caffeine on the phosphorus metabolite 
profile of MHS porcine muscle.
5.3 METHODS
Biopsy samples of skeletal muscle were obtained 
from control and MHS swine using methods described in 
chapter 3. Each sample was dissected into 30mm strips 
of 1mm diameter, four or five of which (ca 300mg) were 
tied to a platinum wire holder and the whole assembly 
placed in a standard 10mm NMR tube. The steps of sample 
preparation are illustrated in Figure 5.1.
31Figure 5.1 Preparation of sample for P NMR
A. Platinum wire muscle holder
B. Five strips of porcine muscle tied to the holder
C. NMR tube containing the assembly and showing the perfusion 
capillaries in position
D. The magnet of the NMR spectrometer. The trolley holds the 
peristaltic pump, the water-bath and the halothane vapooriser. 
The aluminium ladder is to prevent the trolley from being 
drawn towards the magnet.
SPEC_________
DAT
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A recirculating perfusion system was used to keep 
the muscle oxygenated. 200 ml of muscle buffer was
bubbled with carbogen at 37°C. This was pumped to and
from the NMR tube using a peristaltic pump. In order to 
ensure that the NMR tube did not fill and overflow, the 
capillary used to pump buffer out of the tube was 
twice the diameter of the capillary used to pump the 
buffer into the tube. The buffer was pumped to the 
bottom of the tube and drawn off at a height of about 
4cm. The rate of flow of buffer through the system was 
maintained at about 6ml/min. The probe region of the 
spectrometer was kept at 37°C and a towel placed over
the top of the magnet in order to keep the full length
of the magnet bore at 37°C. This provided a method of 
re-heating the buffer, which had cooled in the 
capillary between the reservoir and the magnet.
Halothane was added to the buffer by passing the 
carbogen through a calibrated vapouriser before 
bubbling through the reservoir of buffer, and caffeine 
was added as a powder directly to the reservoir.
31P NMR spectra were recorded at 80.9 MHz on a 
Bruker CXP-200 spectrometer, with an Oxford
Instuments/Spectrospin 4.6T superconducting magnet. As 
a superconducting magnet provides a stable magnetic 
field over the time periods used for these experiments, 
field locking (a system to compensate for drift in the 
magnetic field) was not used. The homogeneity of the 
magnetic field was optimised while observing the 
free-induction decay of the H ^ 0 resonance. The sample
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could not be spun, due to the perfusion apparatus, 
which meant that natural linewidths of the resonances 
were greater than is expected from small molecules in a 
freely moving environment.
Spectra were recorded over 32 min, using 2000
pulses at a repetition rate of Is. A 90° pulse (13psec) -*
was used to perturb the system. A line broadening
factor of 5Hz was applied to the free induction decay
before the Fourier Transform. Chemical shifts were
measured from a secondary reference of 1M methylene
diphosphonic acid (pH 9.0) contained in a capillary
which was placed in the NMR tube. This reference was
chosen because its chemical shift position does not
interfere with the spectral region under study.
However, for presentation, the chemical shifts are
31measured relative to the primary P reference, 85% 
phosphoric acid.
The following standardised protocol was used for 
each experiment using either control or MHS porcine 
muscle. The length of time between the excision of the 
muscle from the pig and its placement into the 
spectrometer was always under lh. The spectrum was 
measured three times, and the resulting spectra 
compared to ensure that the muscle profile was stable.
The drug, either halothane or caffeine, was introduced 
and a period of lOmins allowed for the perfusion system 
to pump the drug to the NMR tube. In this time 10 
complete changes of the buffer around the muscle should 
have taken place. The spectrum was then recorded twice
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more to determine whether or not there was any change.
Having obtained spectra, both before and after the 
addition of the drug, the changes in the spectra can be 
best demonstrated by subtracting one spectrum from the 
other, to produce a difference spectrum. In this 
instance the spectrum obtained before drug addition was 
subtracted from that obtained after.
5.4 RESULTS
In each of the preparations studied, two control 
and two MHS, there was no change in the relative levels 
of any of the metabolites during the first 1.75 hr 
while the three pre-drug spectra were recorded.
The spectra obtained from control muscle before and 
after exposure to 3% halothane or 2mM caffeine are 
presented in figures 5.2 and 5.3 respectively. There 
was no change in the concentrations of any of the 
phosphorus metabolites as shown in the difference 
spectra.
The addition of 3% halothane to MHS muscle did 
result in a change in the spectrum. The phosphocreatine 
peak was reduced in area, while the inorganic 
phosphate resonance showed a comparable increase in 
area, as shown in figure 5.4.
31Figure 5.2 P NMR spectra of control porcine muscle before 
and after the addition of 3% halothane
A. No additions
B. After 3% halothane 
B-A. Difference spectrum
CG
31Figure 5.3 P NMR spectra of control porcine muscle before 
and after the addition of 2mM caffeine
A. No additions
B. ‘After 2mM caffeine 
B-A. Difference spectrum
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31Figure 5.4 P NMR spectra of MHS porcine muscle before 
and after the addition of 3% halothane
A. No additions
B. After 3% halothane 
B-A. Difference spectrum
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31Figure 5.5 P NMR spectra of MHS porcine muscle before 
and after the addition of 2mM caffeine
A. No additions
B. After 2mM caffeine 
B-A. Difference spectrum
The top tracing is the integration of the difference spectrum.
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2mM caffeine produced a similar response in MHS 
muscle (Figure 5.5). The integration of the difference 
spectrum indicates that the decrease in the 
phosphocreatine is equal to the increase in the 
inorganic phosphate.
5.5 DISCUSSION
The results of these experiments are consistent 
with the observed temperature increase during fulminant 
MH. This increase could be due to the hydrolysis of 
ATP, which is then replenished by the creatine 
phosphokinase reaction. If the demand for ATP is 
greater than the ability of glycolysis and of oxidative 
phosphorylation to replenish the energy reserves of the 
cell, then the concentration of PCr will fall. It is 
interesting that the ATP concentration remains 
constant.
Previous investigations have proposed ATP depletion 
as a method of diagnosis for MH, after reporting that 
MHS muscle showed a greater decrease in ATP
concentration during a 30 min incubation than control 
muscle. (Harrison et al., 1969; Nelson et al., 1972;
Britt et al.,1976). These studies found that halothane 
potentiated this response in MHS muscle, while having 
no effect on control muscle. The results of the three 
groups were in reasonable agreement, with between 75% 
and 83% depletion in MHS muscle and between 39% and 52% 
depletion in control muscle. All of these experiments 
were carried out using relatively large pieces of
92
muscle, 800mg (Harrison and Nelson) and 300mg (Britt).
A more recent study found that a 45 min incubation 
in the presence of 4% halothane produced no change in 
the ATP concentration of control muscle and a 19% 
decrease in MHS muscle (Gronert, 1979). Gronert also 
reports that not all MHS muscle showed the depletion in 
ATP. The incubations in these experiments were carried 
out using pieces of muscle weighing 50 - 100mg.
The results presented in this chapter were obtained 
from muscle strips, in which any fibre would not be 
more than 0.5mm from the surface of the muscle sample. 
In this way an adequate supply of oxygen and nutrients 
to all parts of the muscle was ensured. Using this type 
of preparation, it was shown that there was no observed 
ATP depletion in MHS muscle exposed to either halothane 
or caffeine.
This would suggest that the reliability of the ATP 
depletion test is questionable, as it appears that the 
results obtained could depend on the experimental 
procedure. ATP depletion does not appear to reflect a 
metabolic change in MHS muscle.
These experiments could be extended by 
investigating the creatine phosphokinase reaction rate 
in control and MHS muscle, using saturation transfer 
NMR techniques.
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CHAPTER 6 - GENERAL DISCUSSION
6.1 INTRODUCTION
The primary aims of the present studies have been 
to investigate and evaluate the methods of diagnosing 
MH, and to attempt to more fully understand the 
molecular basis of the abnormality in MHS muscle. These 
objectives were achieved, to some extent, using a 
multidisciplinary approach including pharmacological 
and biophysical techniques.
6.2 DIAGNOSIS OF SUSCEPTIBILITY
As yet, there is no non-invasive technique for the 
determination of susceptibility to MH. Therefore, 
in vitro muscle contracture tests continue to be used 
as the only reliable diagnostic methods, however, the 
protocol followed and the criteria used vary 
significantly. An analysis of these methods has been 
used to assess the reliability of each of the tests and 
to develop a standard protocol.
This study was made difficult by the small numbers 
of survivors of known MH episodes, who could be used to 
determine the full range of positive responses to each 
of the tests. For this reason, the drug-induced 
contractures of muscle from suspected MHS patients were 
compared with the contractures of muscle from control 
patients. Using these comparisons, each drug-induced 
contracture was used, in turn, to examine the
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correlation between tests and to assess the relative 
value of the tests.
It was shown that the contracture response of 
muscle to halothane provided the most reliable test of 
MH susceptibility, a finding consistent with its role 
as a major trigger of an in vivo episode of MH. 
Succinylcholine, also commonly incriminated in the 
induction of fulminant MH, was shown to have no effect 
on MHS muscle in vitro, although the preservative used 
in one of the pharmaceutical preparations was shown to 
more often induce a contracture in MHS muscle than in 
control muscle. This response could be used as an 
additional test to confirm a diagnosis of MH
susceptibility.
Caffeine, which was the first drug that was used to 
demonstrate the hypercontractility of MHS muscle, also 
differentiated between susceptible and control 
patients. It provides a useful adjunct to halothane, 
because it can sometimes demonstrate susceptibility in 
patients who would have been diagnosed as normal by a 
halothane-induced contracture response alone.
The use of KCl-induced contracture as a diagnostic 
test is not recommended, since the variation in control 
response is large and, in addition, it was shown that 
pigs, in which the muscle responded to KC1 alone, were 
not susceptible to MH.
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Muscle response to caffeine in the presence of 1% 
halothane was not a reliable method of identifying 
susceptibility to MH. Similarly, the serum CPK 
determination, while useful as a simple test of 
possible susceptibility, often gave both false positive 
and false negative results.
A further method used for the diagnosis of MH has
been the measurement of the rate of ATP depletion in
muscle isolated from humans or swine, and incubated
with oxygen or 3% halothane in oxygen. The phosphorus
31metabolite profiles obtained using P NMR spectroscopy 
indicated that a muscle preparation with an adequate 
supply of oxygen and nutrients is able to maintain the 
ATP concentration at its initial level when exposed to 
either 2mM caffeine or 3% halothane.
In summary, the most reliable in vitro tests are 
the contracture response of muscle to 3% halothane and 
to 2mM caffeine. In our experience, if both of these 
tests are used, all MHS patients will be correctly 
identified. The response of muscle to Anectine and KC1 
should only be used for confirmation of a diagnosis.
The avenues of research which might lead to a
non-invasive method include energy metabolism in
platelets, since the calcium control mechanisms are
similar to those of skeletal muscle (Day and Holmsen, 
1971; Barnhart, 1978). However, previous studies have 
indicated that platelet aggregation, although abnormal 
in some patients (Zsigmond et al., 1978), is not a
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reliable test of susceptibility (Sullivan, 1980).
Investigations of the metabolite profiles of
31erythrocytes using P NMR spectroscopy did not show 
any differences between control and MHS individuals 
(Galloway and Denborough, unpublished results). Energy 
metabolism of skeletal muscle in vivo, using topical 
magnetic resonance (TMR), could also provide a
diagnostic tool. The development of a non-invasive test 
of susceptibility, using a method such as TMR, would 
allow a much larger proportion of the population to be 
tested.
6.3 ENERGY METABOLISM IN MH
31The P NMR studies reported in this thesis have 
demonstrated that, on exposure to halothane or
caffeine, the rate of depletion of phosphocreatine is 
potentiated in MHS muscle. This is consistent with a 
hypermetabolic state in MHS muscle, switched on by the 
presence of certain drugs. If ATP is used at a faster 
rate than glycolysis or oxidative phosphorylation are 
able to replenish it, the creatine phosphokinase 
reaction would be activated by the higher ADPrATP ratio 
and ATP would be produced at the expense of PCr, an 
equilibrium highly favouring the production of ATP.
It is hoped that, in future, the creatine
phosphokinase reaction might be studied using 
saturation transfer techniques in NMR. If a difference 
in the basal rate of this reaction could be measured 
between MHS and control muscle, such a system could
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provide an in vivo test of MH susceptibility using TMR.
6.4 MEMBRANE DEFECTS IN MH
*
Each of the muscle membranes has been implicated in 
the primary MH defect, although the evidence for some 
theories is more convincing than for others. The 
depolarization of MHS swine muscle was previously used 
to suggest that the lesion was at the level of the 
sarcolemma and that dantrolene sodium could reverse the 
depolarization by interacting with the sarcolemma 
(Gallant et al. , 1979). Results in this thesis have
confirmed the observations of Gallant et al. , however, 
further experiments have provided evidence for an 
alternative explanation.
The depolarization of control muscle by 8mM 
caffeine was proposed as a model for the 
halothane-induced depolarization of MHS muscle. This 
drug treatment results in a contracture of control 
muscle due to an increase in the concentration of 
myoplasmic calcium, caused by antagonising the 
sarcoplasmic reticulum (Weber and Herz, 1968). It is 
postulated that the depolarization of control muscle is 
a result of the calcium released from the SR and, 
furthermore, that this model suggests that the 
depolarization of MHS muscle by 3% halothane or 2mM 
caffeine is also due to calcium release from the SR.
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This postulate is consistent with the proposed mode 
of action for dantrolene sodium, which has been used to 
reverse both the contractures (Austin and Denborough, 
1977) and the depolarization (Gallant et al.,1979) 
induced in MHS muscle by 3% halothane. Its mode of 
action has been suggested to be via antagonism of 
intracellular calcium release (Ellis and Carpenter, 
1972) or inhibition of t-tubular or trigger calcium 
release (Putney and Bianchi, 1974).
With further experiments, using D2O to inhibit the 
E-C coupling mechanism, it should be possible to more 
accurately locate the primary lesion.
The isolation of the various muscle membranes would 
also make possible a detailed study of differences 
between MHS and normal muscle. The SR membrane has 
already been the subject of calcium transport studies, 
although the results obtained are not consistent and 
the conclusions drawn are dependent on the nature of 
the preparation and the experimental methods.
It should be possible to investigate
19halothane-membrane interactions using F NMR. The time 
taken for a perturbed nucleus to relax to its ground 
e'nergy state is dependent upon the environment and 
mobility of the molecule containing the excited 
nucleus. If a molecule is bound to a large structure, 
such as a protein or a membrane, the energy of the 
perturbed nucleus can be more rapidly transferred to 
its surroundings. The measurement of this relaxation
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rate, T^, gives information about the environment of
19the molecules. The F nuclei in halothane provide a 
strong NMR signal which can be used to monitor the 
interactions of halothane with membranes. By isolating 
each of the membrane systems, sarcoplasmic reticulum, 
t-tubules and sarcolemma, it should be possible to 
determine whether or not halothane binds to one 
membrane more strongly in MHS muscle than in control 
muscle and to study the effect of dantrolene sodium on 
the binding.
Similar techniques could also be used to
investigate the membranes themselves, using  ^P to
monitor the phospholipids and their mobility. This
would enable the effect of drugs on the stability and
the fluidity of the membranes to be studied. The mode 
of action of dantrolene sodium could also be elucidated 
by observing its effect on membranes before and after 
drug treatment. These methods have already been used to 
investigate the stabilising effect of the calcium 
antagonist, TMB-8, on artificial membranes (Sullivan, 
Galloway and Denborough, 1982).
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APPENDIX
A.l Analysis of control response
Rectus abdominis muscle was obtained from 67 
patients during elective surgery. The use of this 
muscle for control studies was appropriate on the basis 
of the distribution of type 1 and type 2 fibres, which 
was similar to that in vastus lateralis, as shown in 
figure A.l.
A record was maintained of the anaesthetic agents 
used. All patients received thiopentone and nitrous 
oxide, while 24 patients had halothane (between 0.4 and 
1%). In most cases a muscle relaxant, either
succinylcholine, tubocurarine, pancuronium or
alloferrin, was also used. No correlation was observed 
between the anaesthetic used and the muscle response.
The contracture response of the muscle from the 
control patients to each of the drugs, 3% halothane, 
2mM caffeine, 80mM KC1 and 0.4mg/ml Anectine is given 
in table A.l. Also given are the reason for surgery, 
the type of muscle obtained and the age and sex of the 
patient. These factors did not appear to have any 
effect on the muscle response.
It was not possible to obtain sufficient muscle to 
carry out all four tests on each patient. Hence, the 
control data were not able to be analysed in the same 
manner as used for suspected MHS patients (chapter 3). 
For this reason, it was decided to assess each test
Figure A.l Comparison of the muscles used for the study of 
methods of diagnosis of MH
NADH-tetrazolium reductase staining shows a similar distri­
bution of type 1 and type 2 fibres in the two muscles used in 
this study.
A. Rectus abdominis - taken from control patients
B. Vastus lateralis - taken from patients suspected of having
MH.

Table A.l The contracture response of muscle from control patients 
to each of the drugs: 3% halothane, 2mM caffeine, 80mM KC1 and 
0.4mg/ml Anectine.
NAME OPERATION MUSCLE SEX,AGE
V.H. Inguinal Hernia Rectus Abdominis M, 46
E. J. Tubal Ligation Rectus Abdominis F, 33
E.B. Ovarian Cystoscopy Rectus Abdominis F, 44
E.H. Cholycystectomy Rectus Abdominis F , 65
D.L. Cholecystectomy Rectus Abdominis F , 47
M.G. Inguinal Hernia Rectus Abdominis M, 22
M.S. Amputation Vastus Lateralis F, 75
M.D. Cholecystectomy Rectus Abdominis F, 38
H.M. Tubal Ligation Rectus Abdominis F, 30
L.G. ? Rectus Abdominis F, 22
J .A. ? Rectus Abdominis M, 40
N.B. Hysterectomy Rectus Abdominis F, 35- ? Rectus Abdominis F, 39
I .S. Tubal Ligation Rectus Abdominis F, 37
- ? Rectus Abdominis
I.P. Cholecystectomy Rectus Abdominis F, 39
B.C. Cholecystectomy Rectus Abdominis F, 46
E . A . Colostomy Rectus Abdominis M, 66
M.M. Ovarian Cystectomy Rectus Abdominis F, 38
M.D. Cholecystectomy Rectus Abdominis F , 44
L.H. Cholecystectomy Rectus Abdominis F, 28
W.D. Laparotomy Rectus Abdominis M, 62
P.F. Cholecystectomy Rectus Abdominis F, 28
P.K. Cholecystectomy Rectus Abdominis F , 47
V.G. ? Rectus Abdominis F , 48
M.L. ? Rectus Abdominis M,
H.C. Cholecystectomy Rectus Abdominis F , 43
- ? Rectus Abdominis
C. J. Cholecystectomy Rectus Abdominis F, 20
J.P. Hysterectomy Rectus Abdominis F, 31
.A. Hysterectomy Rectus Abdominis F, 31
B.K. Hysterectomy Rectus Abdominis F, 39
J.W. ? Rectus Abdominis F,
.N. ? Rectus Abdominis F,
W.G. Hysterectomy Rectus Abdominis F , 47
C.M. Laparotomy Rectus Abdominis F, 23
J .D. Partial Gastrectomy Rectus Abdominis F, 23
L.Z. Hysterectomy Rectus Abdominis F, 35
C . o . Laparotomy Rectus Abdominis F, 75
R.M. Hysterectomy Rectus Abdominis F, 42
M.T. Hysterectomy Rectus Abdominis F, 39
J.H. Cholecystectomy Rectus Abdominis F, 26
C.K. Exploration Rectus Abdominis F, 28
B.M. Hysterectomy Rectus Abdominis F, 32
D.T. Hysterectomy Rectus Abdominis F, 56
T.D. Colotomy Rectus Abdominis F, 40
N.B. Cholecystectomy Rectus Abdominis F, 48
C.W. Ovarian Cystectomy Rectus Abdominis F, 24
F.T. Cholecystectomy Rectus Abdominis F , 48
B.P. Vagotomy Rectus Abdominis M, 32
- ? Rectus Abdominis F,
B.C. Laparotomy Rectus Abdominis F, 26
L.B. Fallopian TuboplastyRectus Abdominis F,
P.B. ? Rectus Abdominis F,
C. P. Hysterectomy Rectus Abdominis F, 35
D.B. Cholecystectomy Rectus Abdominis F, 32
R. S. Cholecystectomy Rectus Abdominis M, 62
S.S. Cholecystectomy Rectus Abdominis M, 53
H.C. Laparotomy Rectus Abdominis F, 21
M.R. Laparotomy Rectus Abdominis F, 23
A . F . Cholecystectomy Rectus Abdominis F, 27- Hysterectomy Rectus Abdominis F, 49
W.G. ? Vastus Lateralis M,
J .C. Putty platt Deltoid M, 26
A.M. Cholecystectomy Rectus Abdominis F,
G.M. Vagotomy Rectus Abdominis F,
3% HAL 2mM CAFF 80mM KC1 0.4mg/ml ANECTINE
0.05 0.10
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-0.10
-0.05 0.15
0.00
0.00
-0.02 0.03
0.02 0.35 0.15
0.00 -0.02 -0.05 0.00
0.00
0.00
0.37
0.00
0.15
0.10
0.00
-0.05
0.00 -0.05
0.00
0.20
-0.02
0.06
0.00
0.12
0.00
0.00
0.05
-0.03
0.15
0.07
0.03
0.05
0.20 0.15
0.00
0.06
0.03 0.25
0.83
0.02
0.11
0.00
0.04 1.21
-0.01
0.00
0.39
0.00 0.67
0.00 0.020.10
-0.01
0.00
-0.02
0.37
0.00
0.00
0.32 0.16
0.11 0.00
-0.05
0.00
0.20 0.00
0.00
0.04
0.15
0.20
0.32
0.02
0.05
0.10
0.04 -0.02 -0.01 0.04
0.04 0.02 0.00 0.000.00
0.00 0.01 0.04 0.07
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separately and to use the mean plus 2 standard 
deviations as the limit for a control response. By 
definition, this includes 95% of patients, thus leading 
to a 5% false positive rate for each test.
It might be said that the full range of contracture 
responses of control muscle should be used to define 
patients not susceptible to MH. However, this does not 
allow for the possibility of large contractures due to 
an unknown cause and could result in diagnosing a 
number of MHS patients as normal. Due to the serious 
implications of MH it is preferable to over-diagnose 
than to risk giving halothane or succinylcholine to a 
patient who has been wrongly diagnosed as negative.
At this point, it is worth noting that a clinical 
diagnosis should also depend on the patient's family 
history including the reason for suspecting MH. For 
example, a patient whose muscle shows only a marginal 
response to the tests, but who was referred for testing 
because of an observed temperature rise during 
halothane anaesthesia, should be considered susceptible
to MH.
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A. 2 Response of Index Patients
An index patient is defined as the first patient in 
a family to be referred to our laboratory for testing 
susceptibility to MH. The response of muscle from these 
patients to each of the drugs 3% halothane, 2mM 
caffeine, 80mM KC1 and 0.4 mg/ml Anectine is given in 
Table A. 2. Also given are the reason for the referral 
and the age and sex of the patient.
V.
Table A.2 The contacture response of muscle from the index patient 
from suspected MHS families to each of the drugs: 3% halothane,2mM 
caffeine, 80mM KCl and 0.4mg/ml Anectine.
NAME REASON FOR REFERRAL 
NEGATIVE DIAGNOSIS
C.S. Hyperpyrexia after 5 anaesthetics
P.H. Reaction to succinylcholine
P.D. Abnormal response to succinylcholine
P.S. Hyperpyrexia after anaesthetic
J.F. Hyperpyrexia during anaesthesia
R. M. Rigidity during anaesthesia
M.C. Cousin died during anaesthesia
E.M. Son died of MH
J.S. Hyperpyrexia after two anaesthetics
S. E. Hyperpyrexia during anaesthesia
L.C. Hyperpyrexia after anaesthetic
B.W. Son died during anaesthesia
V.S. Son died of MH
V.V. Hyperpyrexia during anaesthesia
POSITIVE DIAGNOSIS
K. R. Brother died of MH
J.M. Niece died of MH
S.H. Brother died of MH
G.M. Cousin died of MH
R. T. Cousin died of MH
S. L. Brother died of MH
V.K. Mother and son developed MH
M.R. Developed MH
J.R. Cousin died during MH
F. R. Hyperpyrexia during anaesthesia
D.H. Brother died of MH
C.W. 3 cardiac arrests during anaesthesia
L. S. Central core disease
R.C. Daughter had anaesthetic complication
B.S. Heatstroke
M. D. Hyperpyrexia during anaesthesia
B. H. Anaesthetic reaction
C. G. MH after succinylcholine
L.O. Son developed MH
J.M. Developed MH
G. H. Brother died of MH
L.O. Central core
J.A. Anaesthetic reaction
L.S. Grandfather reacted during anaesthesia
R. S. Daughter died of MH
S. K. Aneasthetic reaction
P.C. Myopathy
P.W. Grandfather died of MH
Y.M. Hyperpyrexia after anaesthetic
A .G . Daughter died during anaesthesia
SEX,AGE
M, 35 
F, 30 
M, 34 
M, 20 
M,
M, 17 
F, 32 
F , 40 
F, 30 
F, 19 
M, 49 
M, 34 
F, 54 
F, 13
M, 28 
M, 40 
M, 30 
M, 34 
M , 41 
M, 15 
F, 35 
M, 49 
F, 18 
F, 30 
M, 20 
M, 28 
M, 47 
M, 61 
M, 19 
M, 25 
M, 15 
M, 46 
F, 38 
M, 18 
M, 19 
F , 50 
M, 29 
F, 27 
M, 33 
M, 20 
M, 36 
M, 27 
F, 37 
M, 28
105
3% HAL 2mM CAFF 80mM KC1 0.4mg/ml ANECTINE
0.03
0.13
-0.03
0.00
-0.05
-0.15
0.00
0.00
0.00
0.05
0.05 0.00 0.00 0.00
0.03 0.00 0.30 0.00
0.23 0.00 0.00 0.00
0.06 0.00 0.33 0.00
0.00 0.00 0.32 0.00
0.23 0.00 0.13 -0.03
0.19 0.18 0.08 0.14
0.11
0.09
-0.03
0.06
0.00
-0.10 0.30
-0.03 -0.01 0.81 1.27
0.15 0.15 0.13 0.15
4.35 2.21 0.90 1.30
1.67 0.40 -0.05 0.20
3.10 1.45 5.05 0.35
1.15 0.38 0.55 0.20
1.83 0.85 1.45 0.25
3.75 1.85 4.55 1.03
2.40 1.03 0.38 0.39
0.56 0.30 1.10 0.15
0.00 0.10 0.90 1.15
0.30 0.00 0.03 0.18
0.68 0.33 0.35 0.15
1.80 0.23 0.93 0.10
1.80 2.89 1.30 0.43
1.43 1.13 1.24 1.87
0.86 0.60 0.60 0.22
1.72 o . 16 0.08 0.05
2.10 0.16 -0.03 0.05
12.80 0.94 8.95 0.65
1.05 1.05 2.73 1.61
0.73 0.13 0.03 -0.03
1.14 -0.04 0.01 0.30
2.33 1.95 2.64 1.03
0.29 0.23 0.03 0.12
0.37 0.28 -0.02 0.06
6.47 2.66 3.18 2.47
1.54 0.45 0.21 0.60
0.50 0.61 0.18 0.06
1.18 0.22 0.15 0.36
0.35 0.00 0.23 0.00
0.52 0.12 -0.03
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